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General Introduction 
During evolution, the arms race between pathogens and host has been the driving process for bacteria 
to develop specific infection strategies and acquired variety of weapons to fight or avoid host immune 
responses and to establish successful infections. Regarding the Bartonella genus, the comprised 
pathogens evolved a “stealth strategy” characterized by an intraerythrocytic colonization and 
persistence.  
 
1.1.     Prevalence and epidemiology of Bartonella  
 
Bartonella species have been discovered in a wide range of mammals all over the world and can be 
the causative agents of multiple human diseases. The prevalence of Bartonella species in wild animals 
is very high all over the world. Studies revealed that most of deers tested in France and California and 
more than 60% of rodent in central Europe were PCR positive for Bartonella [1, 2]. B. henselae, the 
agent of cat-scratch disease (CSD), is widely distributed among human pets such as cats and dogs. A 
recent study in Germany revealed that over 95% of cats were PCR positive for Bartonella without being 
bacteremic [3]. Another study reported that in Europe 50 out of 94 (53%) stray cat blood samples gave 
a positive culture for Bartonella species (spp.) [4]. The presence of Bartonella among bees, bats, cattle, 
gorilla, horses and many other indicate that Bartonella spp. are highly incident in mammals [5-7] . 
Important to note, coinfection with several Bartonella spp. has been reported in many instances [8].  
Bartonella species can be also causative agents of numerous clinical manifestations and diseases in 
humans. These include Carrion’s disease, CSD, chronic lymphadenopathy, trench fever, chronic 
bacteremia, culture-negative endocarditis, bacilliary angiomatosis, bacillary peliosis, vasculitis and 
uveitis [9-14]. Recently, Bartonella spp. have been also associated with more diverse manifestations 
such as weight loss, hallucinations, muscle fatigue, partial paralysis or neurological manifestations such 
as pediatric acute-onset neuropsychiatric syndrome (PANS) [11, 13, 15]. The severity of the clinical 
manifestation is usually correlated with the immune status of the patient [9]. The diversity of 
Bartonella species and associated diseases, the large spectrum of reservoir hosts and arthropod 
vectors that can transmit these bacteria among mammals and humans turn out to be major causes for 
public health concern and call for more researches on the infection mechanism of the 
underappreciated Bartonella genus. 
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1.2.     The Bartonella genus 
 
The Gram-negative α-proteobacterial genus Bartonella comprises more than 45 fastidious facultative 
intracellular bacteria that cause acute and chronic infections in a broad spectrum of mammals such as 
canids, rodents, ruminants, felids, and humans [16]. Based on a genetic analysis, a robust phylogenic 
tree of the genus Bartonella has been established classifying Bartonella species into 4 distinct lineages. 
The ancestral lineage 1 composed of the deadly B. bacilliformis and the recently discovered B. 
ancashensis (both pathogens associated with Carrion’s disease); Lineage 2 comprises ruminant-specific 
Bartonella species; Lineage 3 consists of closely related Bartonella species; and the most recent and 
species-rich lineage 4 [17-19]. The broad spectrum of hosts for lineage 3 and lineage 4 indicates a 
higher capacity for adaptation compared to lineage 1 and lineage 2, which are limited to human and 
ruminants, respectively (Fig. 1). 
 
 
Host specificity during infection is one hallmark of the genus Bartonella. Each Bartonella species can 
establish a long-lasting intraerythrocytic bacteremia in a group of closely related mammalian reservoir 
hosts [20, 21]. Infection course has been described in natural and experimental animal models, such 
as the B. birtlesii-mouse, B. tribocorum-rat and B. henselae-cat models [22]. Even if the exact process 
of Bartonella infection is still enigmatic, many studies of the infection course demonstrated similar 
outlines suggesting a common infection cycle shared by all Bartonella species in their specific and 
respective reservoir host(s) [23-26]. Following dermal inoculation, the fastidious pathogen Bartonella 
Figure 1.  Phylogenetic structure and 
distribution of the virulence factors 
in the genus Bartonella 
Phylogeny of the genus Bartonella 
with (a) candidatus tokpelaia 
hoelldoblerii as outgroup taxon. The 
phylogenic tree was based on analysis 
of concatenated alignment of 5 core 
protein sequences. Three Bartonella 
clades have been identified: B. apis 
(green), B. tamiae (yellow) and 
eubartonellae. Eubartonellea are 
further classified into 4 lineages 
(shades of orange/pink). The presence 
or absence of the virulence factors are 
reported by full or empty circles, 
respectively. Values above branches 
show bootstrap support values 
(≥70%).  Taken from Segers et al. 
2017. ISME journal  
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colonizes two sequential undetermined niches, the “dermal” and “blood-seeding niche”. After several 
days of replication and a suggested reprogramming in the “blood-seeding niche”, Bartonella are 
released in the bloodstream where they invade erythrocytes until being ingested during an arthropod 
blood meal and subsequently being transmitted to another host (Fig. 2) [27-30]. 
During the following paragraphs, I will describe in detail the infection cycle of Bartonella species, from 
the transmission by arthropods to the colonization of erythrocytes of the infected host, and describe 
the different virulence factors involved in these consecutive stages of infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Schematic description of the Bartonella infection cycle 
(1) Bartonella replicate in the mid-gut of the hematophagous arthropod. (2) During a blood 
meal, Bartonella are shed with the faeces onto the mammalian host skin. When the arthropod 
aspirate blood, it triggers irritation followed by scratching and subsequently by superficial 
inoculation of the bacteria in the dermis of the host. (3) Bartonella colonize DCs defined as 
the “dermal niche” which will disseminate bacteria from the inoculation site to the 
fenestrated lymphatic circulation providing an access to the “blood seeding niche” (4). Process 
that strictly depends on BepE. (5) It is believed that Bartonella colonize ECs as the replicative 
“blood seeding niche” and require the action of BepA, BepC, BepF and BepG. (6) From the 
“blood seeding niche”, Bartonella are periodically seeded into the blood stream where they 
colonize erythrocytes and reinfect a new blood seeding niche for future reinfection waves. (7) 
Bartonella replicate a limited number of times and (8) stay in a slow physiological state. (9) 
Bartonella are ingested during an arthropod blood meal leading to a new cycle of infection in 
another host. Taken from Siamer et al. 2015. Curr. Opin. Microbiol. 
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1.3.     Infection cycle 
 
1.3.1.     Transmission 
 
Bartonella spp. are mainly transmitted between mammals via direct contacts such as scratches and 
bites or by numerous hematophagous arthropods vectors including lice, keds, flies, sand flies, fleas and 
potentially mites, ticks and spiders [31-34]. Current information suggest a highly adapted vector-
species association between Bartonella and the vector, explaining the specificity observed between 
Bartonella species and their vectors (Fig. 1) [35]. When ingested by the vector, Bartonella replicate 
within the mid-gut lumen of the arthropods and are shed either with the faeces onto the mammalian 
skin or by the oral [35-38].  
So far two types of transmission have been demonstrated among the genus Bartonella dependent on 
the feeding behavior of the vector. B. bacilliformis from lineage 1 and the ruminants-specific lineage 2 
species share a common transmission by diptera, sandflies, and keds bites [39, 40]. The aggressive 
feeding behavior of biting arthropods provokes skin damage of the host and bleeding of capillaries 
providing a direct access to the blood for Bartonella by oral shedding [40]. Oral shedding of Bartonella 
via cat biting has also been reported [41]. 
In contrast to this aggressive mode of feeding, arthropods vectors spreading lineage 3 and lineage 4 
Bartonella spp. such as fleas, lice or ticks use a less damaging blood feeding behavior preventing 
Bartonella to have direct access to the bloodstream [42-47]. In this configuration of transmission, 
Bartonella excreted in arthropod’s faeces relies onto the mammalian skin. When the arthropod 
aspirates blood, it triggers irritations followed by scratching and subsequently by superficial 
inoculation of the bacteria into the derma of the host [28, 29, 34, 48]. Unlike B. bacilliformis and lineage 
2 species that have a direct access to the blood, lineage 3 and lineage 4 species have to travel through 
the derma to reach the blood [27]. This step of the infection is named “dermal stage”. 
 
1.3.2.     Dermal stage 
 
Studies on lineage 4 species suggest that the dermal stage of Bartonella infection is characterized by 
the colonization of two consecutive undetermined replicative niches named “dermal niche” and 
“blood-seeding niche” (Fig. 2) [27, 49].  
Up to date, this “dermal niche” remains unclear. However, it has been shown in vitro that lineage 4 
Bartonella species such as B. tribocorum or B. henselae have a tropism for dendritic cells (DCs) [27, 30]. 
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Therefore, DCs were proposed to be the “dermal niche” and might play a role for systemic 
dissemination from the dermal site of inoculation to the “blood-seeding niche” [50]. Indeed, it is 
believed that infected DCs carry Bartonella species into the permeable lymphatic circulation and 
subsequently to the bloodstream where Bartonella can colonize the “blood-seeding niche” [27, 28, 
50]. The lymphatic circulation allows the bacteria to bypass the endothelial barriers, constituted by 
membrane matrix and endothelial cells (ECs), facilitating the access to the bloodstream [50]. The 
colonization of a “dermal niche” is dependent on the feeding behavior of the arthropod.  Since the 
feeding behavior of lineage 2 and B. bacilliformis-vectors provide a direct access to the bloodstream 
and subsequently to the “blood-seeding niche”, these Bartonella species might not have to colonize a 
“dermal niche” [51].  In contrast, because lineage 3 and lineage 4 species are superficially inoculated 
into the derma by scratching, it is believed that the colonization of the “dermal niche” is a crucial step 
to travel through the dermis and reach the “blood-seeding niche”.  
Following the infection of the “dermal niche” Bartonella colonize a “blood-seeding niche” which is also 
not fully determined in vivo [27, 28, 52]. In vitro experiments have shown the tropism of Bartonella 
spp. for ECs and proposed ECs to be the replicative “blood-seeding niche” [27, 29, 50, 51, 53]. In 
contrast to the dermal niche, the colonization of the “blood-seeding niche” is shared by all Bartonella 
lineages. The existence and the essentiality during Bartonella infection of this replicative niche have 
been supported by intravenous rat infection using B. tribocorum where bacteremia appeared only 5 
days post inoculation [51]. It strongly suggests that a replicative niche might be present allowing a 
physiological reprogramming of Bartonella to afterward successfully colonize erythrocytes [51].  
In both niches, Bartonella need to invade mammalian nucleated cells. The initial steps in the infection 
of nucleated cells are the adherence of the bacteria to the extracellular matrix and to the host plasma 
membrane [54, 55]. Such interactions involve surface proteins mediating contact between bacterial 
and host cell surfaces such as the trimeric autotransporter adhesin BadA (Bartonella adhesin A) of B. 
henselae and variably expressed outer membrane proteins (Vomps) of B. quintana [56, 57]. It has also 
been demonstrated for B. henselae that HbpABhe (hemin-binding protein) interacts with the membrane 
of ECs facilitating the entrance of the bacteria [58]. This observation argues in favor of ECs as the “blood 
seeding-niche” in vivo. In addition to promote ECs invasion, hemin binding proteins appear to be crucial 
for Bartonella to survive. Indeed, since Bartonella is a heme auxotroph α-proteobacteria, hemin 
binding and hemin uptake proteins allow the bacteria to process hemin in their environments such as 
the bloodstream of the host and the flea gut [59-61].  Furthermore, hemin binding proteins protect 
the bacteria from toxic concentrations of heme [62]. 
Following this adherence step, Bartonella subvert cellular signaling pathway allowing the persistent 
colonization of the targeted cell. To do so, Bartonella translocate a cocktail of effectors (Bartonella 
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effector proteins – Beps) via a type 4 secretion system (T4SS): the VirB/D4 T4SS [17, 61, 63]. The 
function of the VirB/D4 T4SS and the role of Beps during Bartonella infection will be discussed in more 
detail in paragraph 1.4.1.1 (p. 8) and 1.4.1.2 (p. 10). 
 
1.3.3.     Blood stage 
 
The process of erythrocyte parasitism by Bartonella spp. has been mainly studied in rats infected with 
B. tribocorum [51]. In this model, after residing within the “blood-seeding niche”, the bacteremia onset 
occurs 5-6 days post-infection by a synchronous wave of bacterial release in the bloodstream (Fig. 3) 
[51]. In general, erythrocytes colonization by Bartonella is characterized by four successive steps: 
adhesion, deformation, entry, and replication [22, 52, 64]. 
 
 
During erythrocytes adhesion, studies on B. bacilliformis suggested Bartonella spp. to target proteins 
localized at the surface of the red blood cell such as spectrin, Band3, and glycophorins A and B [65, 66]. 
Interaction between the pathogen and these membrane proteins and attachment to erythrocytes are 
mediated either by the Trw type 4 secretion system (Trw T4SS) or by the flagellum [22, 32, 55, 64]. 
These two virulence factors will be discussed in more details in paragraphs 1.4.2.2 (p. 12) and 1.4.2.3 
(p. 13), respectively.  
Upon attachment, B. bacilliformis and B. henselae cause a severe deformation of the red blood cell 
membrane, which might facilitate the uptake of the bacteria [67, 68]. A small hydrophobic molecule 
Figure 3. Schematic description of the cyclic 
waves of Bartonella spp. intraerythrocytic 
bacteremia in a mammalian reservoir host 
After several abacteremic days post-
inoculation (lag phase), bacteremia is 
initiated with a high number of bacteria in 
the bloodstream (arrow 1) with bacteria 
invading erythrocytes and a new blood 
seeding niche. It is believed that blood 
seeding niches releases synchronously 
bacteria in the bloodstream at regular 
intervals (arrows 2-4) until a specific 
antibody overcome the infection. In some 
cases, bacteremia may peak (arrow 5) after 
several abacteremic days (dormant phase). 
The intraerythrocytic lifestyle of Bartonella 
allow its transmission to other mammalian 
host mediated by blood sucking arthropods. 
Taken from Pulliainen et al. 2011. FEMS 
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named deformin, which is able to bind serum proteins such as albumin, triggers erythrocyte-
membrane deformation [69].  
The exact process of Bartonella entry into erythrocytes remains unclear and, unlike nucleated cells 
infected during the dermal stage, there is no evidence for active membrane transport in erythrocytes 
[55]. However, since Bartonella are able to bind Band3, it has been speculated that the bacteria might 
disturb the overall organization of the red blood cell membrane and its integrity, therefore, facilitating 
the entrance within the cell [32, 66]. A similar invading process has been described for Plasmodium 
falciparum, causative agent of malaria [29]. Furthermore, one study revealed the presence in B. 
bacilliformis of an invasion-associated locus A and B (ialAB) encoding for two membrane proteins 
named IalA and IalB. This locus has been shown to confer an erythrocyte-invasive phenotype when 
expressed in E. coli, indirectly implicating its role in B. bacilliformis erythrocyte invasion [70, 71]. IalA 
is a (di)nucleoside polyphosphate hydrolase which helps bacterial survival during erythrocyte 
colonization by reducing levels of stress-induced dinucleosides. During invasion, IalB is exported to the 
pathogen surface and functions as a crucial invasion factor [70, 71].   
Following adhesion and deformation of the erythrocyte membrane, bacteria are internalized into a 
membrane-bound compartment where they replicate until the critical limit of eight bacteria per 
erythrocyte is reached, which is constant during the remaining life span of the invaded erythrocytes 
[51]. It has been shown that B. tribocorum colonize mature erythrocytes of different ages with similar 
efficiency [51]. After the synchronous erythrocyte invasion on 5-6 days post-infection, the number of 
infected erythrocytes decreases over time due to erythrocyte turnover [51]. However, the initial wave 
of erythrocyte infection is followed by reinfection waves occurring in intervals of 3-6 days suggesting 
that Bartonella, when released in the bloodstream, might re-infect a new “blood-seeding niche” as a 
bacterial reservoir for a future release (Fig. 3) [51]. This cyclic bacterial release in the bloodstream is in 
accordance with cyclic fever relapses in patients affected by the trench fever (five days fever) caused 
by B. quintana [72]. The intraerythrocytic localization has also been demonstrated for other Bartonella 
species such as B. grahamii in mouse, B. henselae in cat or B. bacilliformis in human [24, 67, 73, 74].  
This hemotropism represents a clear advantage for Bartonella to survive in the host by being hidden 
from the immune system and subsequently by being imbibed during an arthropod blood meal, and 
thus transmitted to another host [29]. 
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1.4.     Virulence factors 
 
1.4.1.     The VirB/D4 T4SS and its Bartonella effector proteins 
1.4.1.1.     The VirB/D4 T4SS 
 
The VirB/D4 T4SS is a multi-protein translocation channel that spans the entire cell envelope. The Type 
4 secretion machinery in Bartonella spp. is composed of 11 proteins present in multiple copies (VirB2-
11) and expressed from a conserved operon (Fig. 4). An additional Type 4 coupling protein (T4CP), 
named VirD4 protein, is also expressed but unlike the virB operon, virD4 is expressed under its own 
promoter [75]. It has been reported that the virB operon is under the control of the BatR/BatS two-
component system [76]. BatR expression is controlled by the sigma factor RpoH1, whom levels are 
regulated by the stringent response components DksA and SpoT [76]. By using a sigma factor, 
Bartonella are able to regulate the expression of their virulence factors in response to environmental 
changes such as nutrient availability or pH variation [77-79]. Furthermore, it has been also 
demonstrated that BatR/BatS has an optimum activity at the physiological pH of the blood (pH 7.4) 
[75].  
 
 
The general organization of the VirB/D4 T4SS is divided into 3 major complexes: The core complex (CC), 
the cytoplasmic inner membrane (CIM) and the extracellular pilus (Fig. 4) [80-83]. The CC is a large 
complex spontaneously assembled and consisting of VirB7, VirB9 and VirB10 forming a channel 
Figure 4.  Schematic description of the 
overall organization of the VirB/D4 T4SS 
VirD4 (pink), VirB4 (yellow) and VirB11 
(blue) are ATPases and compose the 
cytoplasmic inner membrane complex with 
VirB3 (orange), VirB6 (purple) and VirB8 
(light green). The core complex consists of 
VirB7 (brown), VirB9 (green) and VirB10 
(light blue). The pilus is composed of VirB2 
(light purple) and VirB5 (light pink). The path 
taken by substrates through the VirB/D4 T4S 
machinery is indicated by red dots. The 
VirB/D4 T4SS spans the entire cell envelope 
and allows the translocation of substrates 
into the target cell. Taken from Waksman et 
al. 2014. Curr. Opin. Microbiol 
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spanning both membranes (inner membrane -IM- and outer membrane –OM-). The CC creates a 
channel through the periplasm of the bacteria and connects the CIM to the extracellular pilus [84]. The 
CIM is composed of two ATPases, VirB4 and VirB11, that provide the energy for the assembly of the 
different parts of the CC and for Bep translocation. The VirB3, VirB6 and VirB8 proteins anchor VirB4 
into the IM and connect the CIM and the CC. The coupling protein VirD4, another ATPase, recruits, and 
transfers cognate substrates to VirB11, which delivers the substrate to the machinery. The three 
ATPases VirD4, VirB4, and VirB11 shared a conserved triphosphate-binding site called walker A motif 
[85]. Any mutation within this sequence arrests substrate transfer suggesting that these subunits 
energize the transfer reaction in an ATP-dependent manner [86-88]. Unlike VirB4 and VirB11, VirD4 
exclusively provides energy for substrate translocation [85]. The extracellular pilus is composed of 
VirB2 and VirB5. Numerous copies of VirB2 that form the filament and VirB5 proteins are localized at 
the extremity of the pilus and might function as adhesin that mediates binding to specific host 
receptors such as integrin or fibronectin [89].  
The similarity of the VirB/D4 T4SS with the bacterial conjugation system suggests that the virB/D4 locus 
was acquired via horizontal gene transfer from a plasmid. In the current model, the virB/D4 T4SS locus 
was independently acquired in all lineage 3 and lineage 4 species and in the recently discovered B. 
ancashensis (lineage 1) with a single primordial effector [17, 90, 91]. Consistently, there is no trace of 
this machinery in the lineage 2 species and in B. bacilliformis (lineage 1) suggesting that they never 
acquired the machinery [92]. Remarkably, these latter species share a similar mode of transmission by 
biting diptera [63]. 
The VirB/D4 T4S machinery has been shown to be crucial for lineage 4 Bartonella species to establish 
a successful colonization of the host. Rat infections with Bartonella strains deficient for virB4 and virD4 
show an abacteremic phenotype suggesting the essentiality of the machinery to establish bacteremia 
[93]. These observations are consistent with the fact that the VirB4 protein is a crucial component of 
the T4S machinery and the coupling protein VirD4 is essential for the delivery of the substrate to the 
machinery [93, 94].  Wild type phenotype was recovered when the mutants were trans-complemented 
confirming that the abacteremic phenotype is associated with deletion of virB4 or virD4. Interestingly, 
the plasmid used for complementation was lost during the blood stage of the infection without any 
impact on the infection. This strongly suggests that VirB/D4 T4SS is only needed during trafficking from 
the “dermal niche” to the “blood-seeding niche”, before the erythrocyte colonization [93]. This 
assumption is also supported by the correlation between the presence of the VirB/D4 T4SS and the 
blood-feeding behavior [63].  Indeed, Bartonella spp. lacking VirB/D4 T4SS (B. bacilliformis and lineage 
2 species) have direct access to the blood and do not have to pass through the dermis (Fig. 1) [17]. 
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During Bartonella infection, the main role of the VirB/D4 T4SS is to translocate Beps and the success 
of Bartonella infection relies on the subversion of host cellular process by these effectors [93, 95].  
 
1.4.1.2.     Bartonella effector proteins (Beps) 
  
The diversity of Beps observed in lineage 3 and lineage 4 is the result of two parallel radiative 
evolutions after an independent acquisition in the lineage 3 and 4 of the VirB/D4 T4SS with a single 
primordial effector suggested to be Bep1 or BepA in lineage 3 and lineage 4, respectively [17, 61]. 
Concerning B. ancashensis (lineage 1), an independent acquisition of the VirB/D4 T4SS locus with a 
single Bep also occurred [18]. A succession of effector gene duplications and functional diversifications 
evolved into complex effector repertoires (Fig. 5) [17].  
 
 
 
 
 
 
 
 
 
 
 
 
Despite these radiative evolutions and diversifications, all Beps among Bartonella spp. share a bipartite 
T4S signal composed of a C-terminal Bep intracellular delivery (BID) domain and a positively charged 
C-tail (Fig. 4) [28, 96]. Because translocation into host cells via the T4SS evolved from DNA conjugation 
machineries, it is believed that the primordial Bartonella effector acquired this bipartite signal from 
relaxases of alphaproteobacterial conjugation systems to facilitate translocation into the targeted cell 
[95, 97]. Furthermore, beyond being only a secretion signal several studies highlight the ability of the 
Figure 5.  Representation of the three Bep repertoires among Bartonella lineages 
The diversification of Beps from B. ancashensis (lineage 1), lineage 3 and lineage 4 species results 
from gene duplication and functional diversification of a primordial effector horizontally acquired 
with the virB locus. It is believed that the acquisition of the virB locus and the ancestral bep occurred 
independently in B. ancashensis (lineage 1), lineage 3 and lineage 4.  All Beps among Bartonella spp. 
share a bipartite Type 4 secretion signal composed of a C-terminal Bep intracellular delivery (BID) 
domain (purple) and a positively charged C-tail. The presence of the FIC domain (orange) and the 
tyrosine phosphorylation (pY) motifs (vertical lines in cyan) is Bep-dependent. Taken from Harms et 
al. 2017. Genome Biol. Evol. 
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BID domain to interact with host cellular function [27, 98]. A striking example is the BID domain of 
BepA from B. henselae that interacts with host adenylyl cyclase and subsequently disturbs cyclic AMP 
production, a second messenger involved in a multitude of cellular functions such as apoptosis [99, 
100].  
In addition to this T4S signal, most of the Beps harbor a N-terminal filamentous induced cAMP (Fic) 
domain mediating post-transcriptional modification such as AMPylation, phosphorylation or 
phosphocholination (Fig. 5) [101-103]. Interestingly, Beps lacking the Fic domain harbor tandem-
repeated pY-motifs mimicking eukaryotic host proteins. These Beps are phosphorylated by host 
cellular kinases allowing the interaction of the effectors with SH2 domain proteins, which are key 
elements in host signaling [95, 104]. Furthermore, Beps-containing pY-motifs are present in lineages 
1,3 and 4suggesting pY-motifs evolved in all three lineages and this motif plays a fundamental role 
during infection (Fig. 5) [96].  
Up to date, the study of Beps has been mainly performed on Beps from B. henselae and in vitro studies 
have demonstrated a variety of cellular phenotypes associated with these Bartonella effectors [105]. 
It is believed that BepE plays a crucial role in infected-DCs migrating from the infection site to the 
“blood-seeding niche” by counteracting the effect of BepC, which may otherwise trigger cell 
fragmentation [27]. BepA prevents apoptosis and protects infected DCs from being cleared by the 
immune system of the host [106]. By hijacking the filamentous actin (F-actin) organization of DCs, 
BepC, BepF, and BepG allow the engulfment of a bacterial cluster within the Bartonella-containing 
vacuole tightly surrounded by actin fibers named “invasome” [27, 29, 100].  Furthermore, in vitro, by 
interacting with the signal transducer and activator of transcription 3 (STAT3), BepD inhibits, on one 
hand, the secretion of the pro-inflammatory cytokine TNFα by DCs and macrophages and, on the other 
hand, stimulates the production of interleukin 10 (IL-10), an anti-inflammatory cytokine. (Unpublished 
data from Y-Y Lu, C. Schmutz, and I. Sorg). Of note, all these experiments have been performed in vitro.  
Taken together, all these findings strongly suggest the significance of the VirB/D4 T4SS and the 
translocation of Bartonella effector proteins during the infection cycle from the inoculation site to the 
“blood-seeding niche”. However, the exact process of the in vivo infection remains unclear and needs 
further investigation to clarify the exact role of Beps during Bartonella in vivo infection. 
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1.4.2.     Trw Type 4 secretion system 
 
The Trw T4SS, restricted to lineage 4 and B. australis, is a multiprotein complex that spans the bacterial 
inner and outer membrane [90]. Unlike VirB/D4, the Trw T4SS does not harbor a coupling protein 
necessary for translocation of substrates and is thus believed to have lost this function during evolution 
[54]. The Trw T4SS of Bartonella spp. is highly homologous to the enterobacterial Trw conjugation 
system encoded by the enterobacterial antibiotic-resistance plasmid pR388 [107]. Genetic studies 
revealed a rather recent lateral acquisition of the trw locus in Bartonella spp. which was followed by 
functional diversification [97]. Consistent with the inability to translocate proteins, host specificity 
allocated to the Trw T4SS is not reliant on effector translocation but on the exposure of specific 
proteins on bacterial surface.  
Indeed, the highly conserved trw T4SS loci are collinear except for the presence of numerous tandem 
repeat gene duplications in B. tribocorum. TrwJ, trwI, trwH, and trwL are present in variable copy 
numbers in the trw locus (Fig. 6) [22]. TrwL and trwJ, homologs of virB2 and virB5 respectively, encode 
for different TrwL and TrwJ proteins, the main components of the pilus, which mediates host 
attachment to erythrocytes and subsequently determine the host specificity (Fig. 6) [22, 32, 52, 108]. 
Indeed, TrwJ paralogs bind specifically glycoprotein Band3 at the surface of red blood cells (RBCs). 
Furthermore, variability of this gene among Bartonella species has a key role in adaptation to new 
mammalian hosts and thus in the adaptive radiation of Bartonella species [22, 52, 109]. Based on the 
essential role of the Trw system for erythrocyte invasion it is conceivable that these variant pili may 
facilitate the interaction with different erythrocyte receptors, either within the reservoir host 
population (e.g. different blood group antigens), or among different reservoir hosts [54].  At present, 
the erythrocytic receptor of TrwL remains unknown [32].  
Remarkably, in the modern lineage 4, the acquisition of the Trw T4SS correlates with the loss of the 
flagella suggesting that Trw T4SS might functionally replace flagella during infection. The significance 
of the Trw T4SS to establish erythrocyte infection has been demonstrated for several Bartonella 
species such as B. henselae, B. tribocorum, B. quintana or B. birtlesii [22, 32, 61, 108, 110]. For each 
Bartonella spp., colonization and intra-erythrocytic persistence are limited to a specific reservoir host, 
where its specificity is defined by the capacity of Bartonella species to adhere exclusively to 
erythrocytes of their reservoir host in a Trw T4SS-dependent manner. A Trw-T4SS deficient Bartonella 
species or a host-unspecific Trw-T4SS lead to a defective intra-erythrocytic infection establishment 
[22]. 
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1.4.3.     Flagella  
 
The flagellum is a rotating semi-rigid helical filament that is anchored within the bacterial membrane 
and driven by the influx of protons or Na+ ions direction confers motility to the bacteria in a liquid 
environment. Flagella are regularly associated with virulence mechanism in many bacterial pathogens 
such as biofilm formation, Pathogen-associated molecular pattern (PAMP), adherence or invasion 
(Escherichia coli, Pseudomonas aeruginosa, Helicobacter pylori or else Salmonella enterica serovar) 
[111-114]. Differences in flagella number, position, and structures among bacterial species underlie 
the bacterial adaptation to a wide range of encountered environment.  
Among Bartonella genus, the flagellum is expressed in the ancestral B. bacilliformis from lineage 1, in 
lineage 2 and in lineage 3 species. The role of flagella during Bartonella infection has been extensively 
described in B. bacilliformis [64, 65, 67, 115]. In vitro, when erythrocytes are infected with B. 
bacilliformis, a reversible binding of the bacteria to red blood cells is observed. This interaction initiates 
irreversible membrane trenches and invagination of erythrocyte induced by the small hydrophobic 
molecule deformin [67, 115]. For B. bacilliformis, combination of the deformin activity with bacterial 
motility leads to a forced endocytosis of the bacteria within a Bartonella-vacuole compartments in the 
erythrocyte cytoplasm [67, 68]. In vitro, a non-motile B. Bacilliformis bound poorly, if at all, to 
erythrocytes. Erythrocytes invasion was reduced by approximatively 98% with an antiflagellin serum 
confirming the key role of flagella in erythrocyte invasion for B. bacilliformis and very likely for other 
flagellated Bartonella spp. [64, 108]. However, is still unclear if the flagella directly bind to RBCs or the 
Figure 6.  Genetic organization of the trw 
locus in B. tribocorum 
Host specificity is determined by the Trw-
T4SS, which mediates erythrocytes 
adhesion. This scheme represents the 
genetic organization of the chromosomal 
trw locus encoding the Trw-T4SS in B. 
tribocorum . One major characteristic of 
the trw locus in Bartonella spp. is the 
partial expansion by gene duplications 
and differentiation of trwL, trwj, trwI and 
trwH, which are determining in host 
specificity. Numbers under the scheme of 
trw locus in B. tribocorum indicate the 
copy number of duplicated genes in other 
Bartonellae. Taken from Pulliainen et al. 
2011. FEMS.  
 
 - General Introduction - 
- 14 - 
 
flagella-dependent mobility of the bacteria enhances the interaction between the bacteria and the 
RBCs. 
1.4.4.     Vbh Type 4 secretion system 
 
As the VirB/D4 T4SS system, the Vbh T4SS is closely related to the conjugative T4S-machineries of other 
Rhizobiales such as the AvhB T4SS on pAT of Agrobacterium tumefaciens [61, 90, 92, 95].  
In Bartonella spp., the Vbh T4SS and its coupling protein TraG are either encoded on a plasmid, like 
pVbh of B. schoenbuchensis, pBGR3 of B. grahamii, or chromosomally in a genomic island related to 
these plasmids [92]. As the sole T4S-machinery in lineage 2 and the fact that its substrate is a toxin 
(VbhT) similar to Beps, it is assumed that this machinery plays a role in pathogenesis. Interestingly, the 
plasmid pVbh of B. schoenbuchensis encoding for the machinery and the T4CP acts as a classical 
conjugation system translocating the toxin VbhT into the targeted cell associated with the relaxase 
suggesting VbhT as an interbacterial rather than an interkingdom effector [92]. Up to date, studies 
demonstrated that VbhT inactivates gyrase and topoisomerase IV by AMPylation [116]. These two 
targets belong to the class of type II isomerase and play a crucial role in DNA topology [116]. Since the 
biological role of the resulting post-transcriptional modifications (PTMs) remains unclear, it needs 
further investigations [116].  
Vbh T4SS, the only secretion machinery presents in lineage 2 and some lineage 4-species, is considered 
as a pathogenic factor crucial for Bartonella infection for these lineages (Figure 1.1) [29]. However, vbh 
locus vestiges with deleterious mutations are observed in some lineage 4 species and traG or/and traA, 
a crucial component in the transfer and replication (Dtr) machinery, are also missing [92]. Vbh T4SS 
appears to be functional only in species that do not encode a functional VirB/D4 T4SS [92]. The 
chromosomally vbh locus represents vestiges of a deteriorating conjugation system and suggests that 
the Vbh T4SS tends to disappear [18]. 
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Aims of the thesis 
The work of my thesis, started in September 2014, can be separated in two parts.  
The first part intended to establish an in vivo infection model for Bartonella lineage 3 species by using 
Bartonella 1-1C, previously described as a rat-specific pathogen. After characterization of the course 
of infection in rats with intradermal and intravenous delivery of the bacteria, I aimed to study the 
contribution of the virB/D4 T4SS, the lineage 3-specific Bartonella effector proteins, and the flagellum 
during the infection process. To do so, I infected rats via the two routes of infection with different B1-
1C mutants. Additionally, I investigated the ability of B1-1C to colonize host erythrocytes by performing 
gentamicin protection assay and FACS analysis on rat infected blood. 
The second part aimed to clarify the contribution of Bartonella effector proteins during in vivo infection 
of lineage 4 by using the well-characterized Bartonella tribocorum infection model. As a first step, I 
infected intradermally and intravenously rats with a strain deficient for all Beps. Following the 
bacteremic phenotype observed with this Bep-free mutant, I reoriented my research on a putative 
additional effector named YopJ. To gain a deeper understanding of the role of this effector, I performed 
in-silico analysis on its prevalence among the Bartonella genus and I infected rats with B. tribocorum 
strains lacking YopJ.  
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Abstract 
 
The Gram-negative α-proteobacterial genus Bartonella comprises arthropod-borne pathogens that 
trigger a long-lasting intraerythrocytic bacteremia. Bartonella infection is characterized by two 
successive stages: the dermal stage characterized by the subversion of dendritic cells and the invasion 
of the lymphatic circulation and, the blood-stage characterized by the colonization of erythrocytes. 
Bartonella species are classified into four different lineages based on a phylogenetic analysis and on 
the nature of the virulence factors involved in the infection process. Studies on lineage 4 Bartonella 
species revealed the involvement of two Type 4 secretion systems (T4SS) during the infection process: 
the VirB/D4 T4SS might assist Bartonella during the dermal stage and the Trw T4SS is suggested to 
contribute to host-specific infection of erythrocytes. Lineage 3 and lineage 4 species harbor a VirB/D4 
T4SS but each lineage translocates a different set of effectors and lineage 3 species harbor flagella 
instead of a Trw T4SS, which is confined to lineage 4 species.  
In this study, investigations on the rat-specific lineage 3 strain Bartonella 1-1C (B1-1C) allowed the 
establishment of a lineage 3 in vivo infection model in rats by developing appropriate growth 
conditions for intravenous (i.v.) and intradermal (i.d.) infections. Compared to the well-studies lineage 
4, rat infected with B1-1C develop bacteremia with a delayed-onset and a shorter duration. FACS 
analysis combined with a gentamicin protection assay on infected blood revealed the inability of B1-
1C to colonize erythrocytes explaining the short bacteremia. This finding is unexpected since one 
hallmark of Bartonella pathogenicity is a persistent intraerythrocytic bacteremia. Finally, in this study 
we perform genetic engineering on B1-1C to generate B1-1C ΔflaA and B1-1C ΔvirD4 in order to 
characterize the role of the flagella and the VirB/D4 T4SS during the lineage 3 B1-1C strain infection 
process. As results, in vivo infections with B1-1C mutants revealed an attenuation of the bacterial 
fitness preventing any conclusion on their contribution during the infection. 
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Introduction 
 
The facultative intracellular α-proteobacterial genus Bartonella comprises Gram-negative arthropod-
borne pathogens characterized by a long-lasting intraerythrocytic parasitism in their specific mammal 
reservoir host(s) [1-7]. From the dermal inoculation to the bloodstream, Bartonella species are known 
to invade two sequential niches, the dermal niche and the blood-seeding niche considered to comprise 
dendritic and endothelial cells, respectively [8, 9]. When Bartonella is released into the bloodstream, 
it colonizes erythrocytes and replicates within a vacuolar membrane-bound compartment until 
reaching the critical number of height bacteria per cell. Then, Bartonella persists intracellularly in a 
non-proliferating state for the remaining lifetime of the erythrocyte, an immune-privileged 
environment [3, 9]. According to the nature of the virulence factors involved during the infection 
process and based on a phylogenetic analysis Bartonella spp. are divided into 4 different lineages [10, 
11]. The ancestral lineage 1 composed of the deadly B. bacilliformis and the recently discovered B. 
ancashensis (pathogens associated with the Carrion’s disease); Lineage 2 comprises ruminant-specific 
Bartonella species; Lineage 3 consists of closely species; and the most recent and species-rich lineage 
4 [12]. 
Based on the well-characterized infection cycle of the lineage 4 strain Bartonella tribocorum, two Type 
4 secretion systems (T4SS) are engaged during the infection process: the VirB/D4 T4SS involved during 
the dermal stage and the Trw T4SS involved during the blood stage. Translocation of Bartonella 
effector proteins (Beps) via the VirB/D4 T4SS has been identified as a critical virulence mechanism for 
a successful infection [13, 14]. Horizontal acquisition of the same virB/D4 T4SS locus with a single 
ancestral effector has occurred independently in lineage 3, lineage 4 and in B. ancashensis (lineage 1), 
and was followed by chromosomic integration [12, 15-17]. The parallel evolution of these sets of 
effectors, driven by the pathoadaptation to the host, led to the emergence of three distinct arsenals 
[10, 12, 18].  
The success of the infection relies also on the capacity of bacteria to colonize erythrocytes. Adhesion 
of the bacteria to erythrocytes is mediated by the Trw T4SS in Bartonella lineage 4 or by the flagella 
for species of the other lineages. During infection it has been speculated that the interaction between 
the bacteria and membrane protein Band3 disturbs the integrity of the red blood cell membrane 
promoting the entrance of Bartonella [1, 19-23]. Remarkably, the genomic analysis highlighted that 
the Trw T4SS is confined to lineage 4 spp. and it is assumed that it functionally replaced the flagella as 
a host-specific virulence factor for erythrocytes invasion [1, 5, 19, 22]. Acquisition of the Trw T4SS may 
have led to an increased capacity for host adaptation explaining the extensive adaptive radiation 
observed for lineage 4 species compare to other lineages [5, 12, 15].  
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Concerning host specificity, we know that in lineage 4 it is also mediated by the Trw T4SS [1, 24, 25]. 
Although the Trw T4SS is lacking in lineage 3 species, host-specificity in these lineage 3 species has 
been reported [12, 26]. Up to date, we know that B. rochalimae (Bro) is Canidae-like specific such as 
dog or foxes [27] while, B. clarridgeiae (Bcl) is cat-specific [28] and B. AR15-3 (BAR15) is red squirrel-
specific [29]. So far the exact process of host specificity and erythrocyte colonization remains unknown 
for lineage 3 species but since they bear flagella instead Trw T4SS, it is conceivable to believe that the 
flagellum plays a major role in erythrocyte adhesion and/or colonization as a mechanical force or as 
an adhesion mechanism [30].  Studies on B. bacilliformis (lineage 1) reported that obstruction of 
flagella by antibodies decreased significantly adhesion to erythrocytes and flagella deficient B. 
bacilliformis strain does not bind to erythrocyte [21]. Remarkably, flagella from B. bacilliformis alone 
do not attach to erythrocytes indicating that the interaction between flagellated Bartonella and 
erythrocytes remains unclear [31].  
Since lineage 3 species harbor a different arsenal of Beps from lineage 4 spp. [10, 12, 18] and possesses 
a flagellum instead of a Trw T4SS [5, 12], we were interested in studying the infection cycle of this 
lineage. Bartonella 1-1C (B1-1C) appeared to be the best lineage 3-candidate to work in vivo for several 
reasons: firstly, phylogenetic analysis on housekeeping genes classifies B1-1C as a lineage 3 species like 
B. clarridgeiae (Bcl), B. AR15-3 (BAR15) and B. rochalimae (Bro) [32]. Secondly, B1-1C harbors a set of 
effectors named Bep1 to Bep10 which are different from lineage 4 species. Thirdly, Bartonella 1-1C 
was isolated from Rattus norvegicus in Taiwan suggesting B1-1C to be the only lineage 3 species known 
so far having rat as a natural reservoir host, which was convenient for our in vivo laboratory studies 
since we worked with Wistar rats, a strain of Rattus norvegicus domestica [33].  
 
In this study, we establish the appropriate growth conditions for successful intravenous (i.v.) and 
intradermal (i.d.) infection with the lineage 3 B1-1C strain.  We then compared the infection cycle with 
the one of the well-characterized lineage 4 Bartonella tribocorum and gentamicin protection assay and 
FACS analysis of infected blood were performed to evaluate erythrocyte colonization. Finally, we 
genetically manipulate B1-1C to generate B1-1C ΔflaA and B1-1C ΔvirD4 to have a better understanding 
of the role of the flagella and the VirB/D4 T4SS during the lineage 3 B1-1C species infection process. 
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Results 
As there was no experimental infection model for lineage 3 to date, the interest in first place was to 
characterize the infection kinetic. 
 
Determination of optimal laboratory growth conditions for reliable intradermal 
(i.d.) and intravenous (i.v.) rat infections 
  
Our first goal was to establish more appropriate laboratory growth conditions for reliable i.d. and i.v. 
rat infections. In the literature, Bartonella spp. are mainly grown on enriched-media such as HIA (Heart 
infusion agar), CBA (Columbia blood agar) or TSA (Tryptic Soy agar) media supplemented with blood at 
35°C in a moist atmosphere with 5% CO2. Adding blood to the media provides a crucial source of hemin 
since Bartonella spp. are unable to synthetize this growth factor [34, 35]. In previous rat infections with 
lineage 3 species performed in our group, P. Engel cultivated bacteria for 3-5 days on TSA plates 
supplemented with 5% of defibrinated sheep blood [12]. Taking into account that there are medium- 
and temperature-dependent growth differences in vitro between diverse isolates of the Bartonella 
genus, we compared two different growth media (HIA and TSA) and different cultivation times to 
optimize the laboratory growth conditions [36]. We decided to test HIA rather than CBA because HIA 
is the growth medium generally used for the well-described B. tribocorum in vivo infections. To note, 
Bartonella spp. can be grown between 35-37°C but with a significantly higher growth rate at 35°C 
explaining our choice to grow bacteria at this temperature in a humidified environment [36].  
Groups of 5 rats were intradermally infected with B1-1C WT strain grown either on HIA for 3 days (Fig. 
1A), 7 days (Fig. 1B) or 10 days (Fig. 1C) or on TSA for 3 days (Fig. 1D). A correlation between the 
cultivation time on HIA plates and the rate of infection was observed, showing that the longer was the 
cultivation on plates the higher was the infection rate (Fig. 1A, B, C). Thus, we assumed that over time 
the nutrient availability on plate decreased, thereby inducing a stringent response in the bacteria 
leading to the expression of the VirB/D4 T4SS [6]. This assumption was supported by previous data 
showing that the expression of the VirB/D4 T4SS in Bhe (Lineage 4 species) is under control of the 
stringent sigma factor RpoH1 and the BatR/BatS two-component system [37].  
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In contrast to HIA plates, cultivation on TSA plates for 3 days was already sufficient for B1-1C WT to 
reach an infection rate of 100% and showed a higher reproducibility (Fig. 1D). Remarkably, since the 
infection rate was 100% after 3 days of growth on TSA, we did not test other growth times on this 
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Figure 1: Determination of the appropriate growth conditions for reliable i.d. and i.v. rat infections 
Groups of 10 weeks old Wistar rats were intradermally infected (inoculum 1x107 CFUs, n = 5) in the ear with B1-1C WT. Bacteria 
were grown for 3 days at 35°C and 5% CO2 on either HIA or TSA plates supplemented with defibrinated sheep blood. Plotted 
graphs represent time course of single animals (indicated by the different animal numbers) from which bacteria were 
recovered at a given time point post-infection. Each value corresponds to an average (CFU/ml of ml of blood) acquired from 
serial dilutions. Graphs (A), (B) and (C) represent bacteremia triggered by B1-1C WT grown on HIA plate for 3, 7 or10 days, 
respectively. Graph (D) represent bacteremia triggered by B1-1C WT grown on TSA for 3 days. Table next to the graphs 
indicates the mean of the onset, the duration, the maxmimum titer and the infection rate of the bacteremia. 
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media in order to reduce the number of animals for experimentation (Reduce, Replace, Refine – Animal 
welfare). 
Based on these data, growing B1-1C WT on TSA plates supplemented with defibrinated sheep blood 
for 3 days at 35°C with 5% CO2 turned out to be the more appropriate growth conditions for our in vivo 
experiments. Therefore, we didn’t test CBA media in order to save animals. 
 
Generation and analysis of the streptomycin-resistant B1-1C strain (B1-1C SmR) 
  
During the procedure of gene replacement, we used a suicide mutagenesis vector harboring a 
kanamycin cassette for the positive selection and a streptomycin sensitive cassette for the negative 
selection (described in the materials and methods section). Thus, we generated the streptomycin-
resistant strain B1-1C SmR to allow the selection of bacteria having lost the mutagenesis plasmid during 
the second homologous recombination on HIA plates supplemented with streptomycin. 
Streptomycin resistance is mediated either by mutations in the rpsL gene encoding the ribosomal S12 
protein or, less frequently, in the 16s rRNA gene [38]. We generated a spontaneous streptomycin-
resistant B1-1C mutant by spreading bacteria on TSA plates containing streptomycin at a concentration 
of 100 µg/ml. Grown bacteria were sequenced and we selected a mutant carrying the K43R mutation 
in the S12 protein encoded by the rpsl gene. The K43R mutation was chosen because of its high 
frequency in nature and its reliability in both genetic selection and complementation [39, 40]. 
To assess a potential effect of the streptomycin resistance on bacterial fitness of B1-1C WT, we infected 
intradermally groups of rats with either B1-1C WT or B1-1C SmR and monitored bacteremia (Fig. 2A, 
B).  Compared to B1-1C WT, animals infected with B1-1C SmR developed bacteremia with no difference 
for neither the onset, the duration nor the titer (Fig. 2D). A two-way ANOVA test comparing bacteremia 
curves of B1-1C WT and B1-1C SmR confirmed that there was no significant difference (p-value = 
0.7731). Therefore, B1-1C SmR was used for further genetic manipulations and animal infections in this 
study.  
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Figure 2: B1-1C SmR triggers bacteremia not significantly different from B1-1C WT 
Bacteria were grown for 3 days at 35°C and 5% CO2 on TSA plates supplemented with 5% of defibrinated sheep blood. Plotted 
graphs represent time courses of single animals (indicated by the different animal numbers) from which bacteria were recovered 
at a given time point post-infection. Each value corresponds to an average (CFU/ml of blood) acquired from serial dilutions. (A, B) 
Groups of 10 weeks old Wistar rats were intradermally infected (inoculum 107 CFUs, n = 5) with either (A) B1-1C WT or (B) B1-1C 
SmR. Animals infected with B1-1C SmR showed no significant difference with animals infected with B1-1C WT. (C) Groups of 10 
weeks old Wistar rats were intravenously infected (inoculum 2x108 CFUs, n = 5) with B1-1C SmR. Values indicated next to the graphs 
correspond to the means and standard deviations of the onset, the duration, the maximum titer and indicate the infection rate of 
bacteremia induced by the same Bartonella strain in different animals (n = 5). (D) t-test were performed to compare bacteremia 
onset duration and maximum titer between B1-1C WT (i.d.) vs. B1-1C SmR (i.d.) and B1-1C SmR (i.d.) vs.  B1-1C SmR (i.v.).  
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Compared to i.v. infection, bacteremia induced by B1-1C SmR via i.d. route shows 
a delayed onset  
 
The Bartonella infection cycle is characterized by two consecutive stages, the dermal stage, and the 
blood stage. Intradermal injections mimic the natural way of infection, while intravenous injections 
bypass the dermal stage. We used these two routes of infection to clarify at which stage of the infection 
the virulence factors are required, such as the VirB/D4 T4SS, the Beps or the flagellum. Therefore, we 
analyzed the bacteremia course caused by B1-1C SmR via the two different infection routes (i.d. / i.v.)   
A group of rats was intravenously infected with B1-1C SmR and bacteremia was monitored (Fig. 2C) and 
compared to the group of rats intradermally infected with the same strain (Fig. 2B). The onset was 
significantly different between both groups (p-value = 0.0006) (Fig. 2D) and the delayed-onset 
observed for the i.d. group was most likely due to the time needed for Bartonella to reach the 
bloodstream from the dermal inoculation site (Fig. 2B, C). In accordance with published data for lineage 
4, after i.v. infection bacteria were detected in the blood 5 days post-infection following colonization 
of a blood-seeding niche [8, 9]. No significant difference was observed regarding duration and titer of 
the bacteremia between the two strains. (Fig. 2D) 
To notice, we assumed that the second peak observed in the i.v. group at days 33 post-infection for 3 
rats out of 5 was related to a contamination during plating.  
 
Compared to Btr WT (lineage 4), B1-1C SmR triggers a delayed and shorter 
bacteremia  
 
Since we had now established B1-1C as an appropriate in vivo infection model for lineage 3, we 
compared its bacteremia to the most studied lineage 4-strain B. tribocorum allowing us to analyze any 
difference in the infection cycle of B1-1C. 
Rats were intradermally infected with either Btr WT (Fig. 3A) or B1-1C SmR (Fig.3 B). By comparing 
bacteremia of these two strains, we first observed a high heterogeneity of bacteremia titer for B1-1C 
SmR oscillating between 104 to 107 CFUs/ml of blood, whereas the Btr WT bacteremia titer oscillated 
between 105 and 106 CFUs/ml of blood. Despite this heterogeneity, the bacteremia titer did not 
significantly differ (p-value = 0.1329) whereas the bacteremia onset and duration were significantly 
different (p-value < 0.0001 for both features) (Fig 3C). These impairments of the bacteremia triggered 
by B1-1C (delayed onset and shorter duration) suggested that lineage 3 B1-1C strain might behave 
differently in vivo than the lineage 4 Btr species. 
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Figure 3: Compared to Btr WT, B1-1C SmR triggers a delayed and shorter bacteremia  
Groups of 10 weeks old Wistar rats were intradermally infected in the ear with either (A) Btr WT (inoculum 1x107 CFUs, n = 
10) or (B) B1-1C SmR (inoculum 1x107 CFUs, n = 13). During 3 days, Btr WT was grown on HIA plates and B1-1C-SmR on TSA 
plates supplemented with defibrinated sheep blood. Plotted graphs represent time courses of single animals from which 
bacteria were recovered at a given time point post-infection. Each value corresponds to an average (CFU/ml of blood) 
acquired from serial dilutions. Each color shade represents a cohort of animal infected the same day with bacteria from the 
same bacterial solution and the tables next to the graph correspond to the mean of the onset, duration, maximum titer and 
indicate the infection rate between all bacteremia. (C) t-test were performed to compare bacteremia onset (C), duration 
(D) and maximum titer (E) between Btr WT (i.d.) vs. B1-1C SmR (i.d.).  
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B1-1C SmR does not invade rat erythrocytes 
 
Bartonella tribocorum, like other Bartonella species, use an infection strategy characterized by a long-
lasting intraerythrocytic colonization providing protection against the host’s immune system and 
enabling transmission by blood sucking arthropods [1, 5, 6]. In lineage 4 species, the host specific 
colonization of red blood cells is mediated by the Trw T4SS [1]. 
Since B1-1C expresses a flagellum instead of a Trw T4SS, we aimed to explore the ability of B1-1C to 
invade erythrocytes. We used flow cytometry to analyze infected-blood samples and to subsequently 
detect bacteria association with erythrocytes. Thus, we generated a B1-1C-gfp SmR strain by inserting 
a transposon containing a gfp expression cassette under the control of a constitutive promoter into 
the B1-1C SmR chromosome. GFP (Green Fluorescence Protein) expression was validated by flow 
cytometry (Fig. 4). Then, we intravenously infected one rat with of B1-1C-gfp SmR to monitor 
bacteremia (Fig. 5). Compared to B1-1C SmR (Fig. 2B) there was no significant difference for the onset 
(p-value = 0.8711), the duration (p-value = 0.5041) and the maximum titer (p-value = 0.2981). 
Since our B1-1C-gfp SmR strain exhibited a bacterial fitness comparable to B1-1C SmR, we performed 
intravenous rat infections with either B1-1C-gfp SmR or Btr- gfp. At day 11 post-infection, blood from 
infected animals was collected from the tail vein, diluted in PBS and analyzed by flow cytometry. 
Recorded GFP-positive events were gated into two populations according to the size (FSC-A): “Single 
bacteria” and “Blood cell-associated bacteria” (Fig. 6A, B). Then, we compared the distribution of B1-
1C-gfp SmR and Btr-gfp between these two populations (Fig. 7A, B).  In addition to the 1:80 dilution, 
we also performed a 1:500 dilution of the blood discriminating doublets from our analysis. In that 
analysis, we name doublets when a bacterium and a red blood cell pass through the laser at the exact 
same time and are counted as associated events while it is not the case. By increasing the dilution rate, 
we reduced the probability of this event.  
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Figure 6: Analytic process of FACS data 
(A) Blood samples were analyzed by flow cytometry. 
Ex 488 versus GFP-A dot blot analysis allowed the 
isolation of population of GFP-positive events. (B) 
SSC-A versus FSC-A analysis of the previously gated 
GFP-positive events allowed distinction of single 
bacteria contained in gate 1 and blood-associated 
bacteria contained in gate 2. FACS pictures are from 
1:500 dilution data. To notice, FSC-A is proportional 
to cell-surface size. 
A. B. 
Figure 4: FACS validation of the constitutive expression 
of GFP in B1-1C-gfp SmR 
B1-1C- gfp SmR was harvested after 5 days of cultivation 
on TSA plates and diluted in PBS (1:1000 dilution). The 
diluted sample of B1-1C- gfp SmR was analyzed by flow 
cytometry. SSC-A versus GFP-A dot blot analysis allowed 
the validation of GFP expression for B1-1C- gfp SmR 
characterized by a shift on the GFP x-axis. SSC-A (Side-
scattered light) corresponds to the cell granularity. 
GFP-A 
SS
C
-A
 
B1-1C-SmR-gfp 
B1-1C-SmR 
B1-1C SmR B1-1C-gfp SmR 
Figure 5: Bacteremia of the B1-1C-gfp SmR strain 
One 10 weeks old Wistar rats was intravenously 
infected (inoculum 2x108 CFUs, n = 1) in the tail vein 
with B1-1C-gfp SmR. B1-1C-gfp was cultivated for 3 days 
at 35°C and 5% CO2 on TSA plates supplemented with 
defibrinated sheep blood. Plotted graphs represent 
time course of single animals from which bacteria were 
recovered at a given time point post-infection. Each 
value corresponds to an average (CFU/ml of blood) 
acquired from serial dilutions. One rat out of 3 showed 
a bacteremia comparable to B1-1C SmR and was 
therefore used for further experiments. Values 
indicated next to the graphs correspond to the onset, 
the duration and the maximum titer of bacteremia. A 
statistical t-test was performed to compare bacteremia 
onset, duration and maximum titer between B1-1C-gfp 
SmR and B1-1C SmR. 
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In accordance with the intraerythrocytic lifestyle of Btr WT [9], 84.5% (1:80 dilution) and 86% (1:500 
dilution) of Btr-gfp were gated as blood cell-associated bacteria and 11%  (1:80 dilution) and 12% 
(1:500 dilution) were gated as single bacteria. A t-test confirmed that there was no significant 
difference between the two dilution for each group of bacteria. In contrast, 63.5% of B1-1C-gfp SmR 
positive events were gated as blood cell-associated bacteria for the 1:80 dilution and dropped to 22% 
for the 1:500 dilution. Consistently, the percentage of B1-1C-gfp SmR positive events gated as single 
bacteria increased from 31% for the 1:80 dilution to 76.5% for the 1:500 dilution. Statistical analysis 
confirmed that there was a significant difference between both dilutions for single bacteria (p-value = 
0.0078) and blood cell-associated bacteria (p-value = 0.0053). Taken together, these observations 
suggested that B1-1C SmR might not be able to colonize erythrocytes. 
To confirm the hypothesis that B1-1C SmR has a non-intraerythrocytic life style, we performed a 
gentamicin protection assay.  Gentamicin is an aminoglycoside antibiotic that cannot penetrate intact 
eukaryotic cell membranes and therefore kills only extracellular bacteria while intracellular bacteria 
are protected [41]. Here, we intravenously infected rats with either B1-1C SmR or Btr WT and collected 
blood at different time points after infection. Then blood samples were treated with gentamicin and 
erythrocytes were lysed as mentioned in the material and method section. For each infected animal, 
CFUs were counted and presented as graph column (Fig. 8A, B, C, D). In contrast to Btr WT (Fig 8A, B), 
when we performed a gentamicin treatment on blood samples from rats infected with B1-1C SmR (Fig. 
8C, D) we did not observe any CFU after plating confirming the incapability of B1-1C SmR to invade 
erythrocytes at any time during the infection. 
Taken together, FACS data and Gentamicin protection assay results strongly suggest a non-
intraerythrocytic life style for B1-1C SmR. 
 
Genetic engineering on B1-1C SmR leads to unspecific attenuation 
 
Bartonella 1-1C translocate via the VirB/D4 T4SS a different set of effectors compared to lineage 4 
species and harbors a flagellum instead of the Trw T4SS. Therefore, to analyze the role of these 
virulence factors during B1-1C infection we generated two B1-1C SmR mutants: B1-1C ΔvirD4 SmR 
harboring an in frame deletions of virD4 and B1-1C ΔflaA SmR harboring in frame deletions of flaA.  For 
each mutant, we infected rats intradermally or intravenously and monitored bacteremia (Fig. 9A, B).  
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Figure 7: FACS analysis of blood infected with Btr-gfp or B1-1C-gfp SmR 
Groups of 10 weeks old Wistar rats were intravenously infected in the tail vein (inoculum 2x108 CFUs, n = 2) with either Btr-
gfp or B1-1C-gfp SmR. At day 11 post-infection, blood from infected animals was collected from the tail vein, diluted in PBS 
and analyzed by flow cytometry. GFP-positive events were gated into two different populations: “Single bacteria” and 
“Blood cells-associated bacteria”. We performed two dilutions 1:80 (white columns) and 1:500 (grey columns). For each 
graph, values the represent the mean of the percentage of GFP-positive events from the two animals infected by either (A) 
Btr-gfp or (B) B1-1C-gfp SmR. Our data suggested a non-intraerythrocytic life style for B1-1C SmR compared to BtrR WT. A t-
test was performed to compare the two dilution. Statistical was performed by using a T-test. 
Figure 8: Gentamicin protection assay 
Ten weeks old Wistar rats were intravenously infected (inoculum 2x108 CFUs, n = 2) in the tail vein with either Btr WT (A, B) 
or B1-1C SmR(C, D). During 3 days, Btr WT was cultivated on HIA plates and B1-1C SmR on TSA plates supplemented with 
defibrinated sheep blood. Blood from infected rats was collected at different time points and treated with gentamicin as 
mentioned in the material and methods section. For each infected animal, treated and untreated blood were plated on HIA 
plates and CFUs were counted and presented as graph column. Grey columns show untreated blood, black columns show 
gentamicin-treated blood and patterned columns show the control. Our data suggested that B1-1C SmR was non-
intraerythrocytic. Efficiency of gentamicin was proven by the absence of CFU from the control. 
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Both strains were abacteremic in i.d. and i.v. infections suggesting either a key role of these two 
bacterial components during infection or a potential polar effect of the deletion. Of note, the lack of 
in vitro infection model for B. 1-1C hampered us to assess any growth defect due to the deletion. 
To investigate further the role of these virulence factors in vivo, complementation experiments were 
performed by expressing virD4 or flaA in trans on a plasmid under the control of the natural promoter 
in B1-1C ΔvirD4 SmR or B1-1C ΔflaA SmR, respectively. Rats were infected intradermally or 
intravenously and bacteremia was monitored (Fig. 9C, D). Bacteremia was not restored independently 
of the infection route indicating that complementation of the mutant was not successful and 
preventing any conclusion about the role of the two virulence factors during the infection of B1-1C 
SmR. The lack of an in vitro infection protocol for B1-1C hampered the analysis of the complementation. 
Finally, to track down any impact of genetic engineering on bacterial pathogenicity, we infected 
intravenously rats with three revertant clones of either B1-1C ΔvirD4 SmR and B1-1C ΔflaA SmR and 
bacteremia was monitored (Fig 9E, F). Interestingly, bacteremia was not restored indicating that 
genetic manipulation and/or successive in vitro passages affects negatively B1-1C SmR fitness. 
Of note, we named revertant strain when the mutant restores its WT genomic situation following the 
excision of the suicide plasmid by the second homologous recombination (described in the materials 
and methods section). 
 
B1-1C SmR does not trigger bacteremia in BALB/c mice indicating host specificity 
in trw-lacking species 
 
Host specificity has been shown in vitro to be mediated by the Trw T4SS in lineage 4 species [1]. Since 
lineage 3 comprises Trw-lacking species we were interested to investigate the host specificity in B1-
1C. Therefore, we intradermally infected BALB/c mice with B1-1C SmR (Fig. 10). None of the infected 
mice developed bacteremia indicating that host specificity is maintained in lineage 3 species even if 
they are lacking the Trw T4SS [6]. To notice, it confirmed a previous experiment demonstrating host 
specificity in lineage 3 where B. 1-1C was the only species triggering homogenous bacteremia in rats 
[12].  
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Figure 9: Determination of the role of the VirB/D4 T4SS and the flagellum during B.1-1C-SmR infection 
Bacteria were grown for 3 days at 35°C and 5% CO2 on TSA plates supplemented with defibrinated sheep blood. Plotted 
graphs represent bacteria which were recovered from single animals at a given time point post-infection. Each value 
corresponds to an average (CFU/ml of blood) acquired from serial dilutions. (A, B) Groups of 10 weeks old Wistar rats were 
intradermally (inoculum 107 CFUs, n = 3, filled symbols) or intravenously (inoculum 2x108 CFUs, n = 3, unfilled symbols) 
infected with either (A) B1-1C ΔvirD4 SmR or (B) B1-1C ΔflaA SmR. No infected animals showed any bacteremia suggesting a 
fitness loss for B1-1C SmR associated with the deletion of either virD4 or flaA. (C, D) Groups of 10 weeks old Wistar rats were 
intradermally (inoculum 107 CFUs, n = 3, filled symbols) or intravenously (inoculum 2x108 CFUs, n = 3, unfilled symbols) 
infected with either (C) B1-1C SmR ΔvirD4-pvirD4 or (D) B1-1C SmR ΔflaA-pflaA. Both complemented strains were 
abacteremic preventing any conclusion about the role of the VirB/D4 T4SS and the flagellum during B1-1C SmR infection 
cycle. (E, F) Groups of 10 weeks old Wistar rats were intravenously (inoculum 2x108 CFUs, n = 1) infected with one of the 
three clones of either (E) B1-1C ΔvirD4 SmR revertant or (F) B1-1C ΔflaA SmR revertant. Each rat was infected with one clone. 
No infected animals showed any bacteremia suggesting a fitness loss for B1-1C SmR associated with genetic engineering 
and/or in vitro passages. 
 
 
  
 - Research Article I - 
- 39 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Assessment of B1-1C SmR’s ability to infect BALB/c mice 
Bacteria were grown for 3 days at 35°C and 5% CO2 on TSA plates supplemented with defibrinated sheep blood. Plotted 
graphs represent bacteria which were recovered from single animals at a given time point post-infection. Group of BALB/C 
mice were intradermally infected (inoculum 107 CFUs, n = 5) with B1-1C SmR. No infected animals showed any bacteremia 
suggesting B1-1C was incompetent to infect BALB/c mice. 
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Materials and Methods 
 
Bacterial strains and growth conditions  
The bacterial strains used in this study are listed in Table 1. Bartonella 1-1C strains were grown either on Tryptic soy agar 
plates containing 5% defibrinated sheep blood (TSA plates) or on heart Infusion Agar containing 5% defibrinated sheep blood 
(HIA plates) at 35°C in a moist atmosphere under 5% CO2 for, if no contraindications, 5-6 days. Bartonella tribocorum strains 
were grown on HIA plates at at 35°C in a moist atmosphere under 5% CO2 for 2-3 days. When indicated, media were 
supplemented with 30 μg/ml kanamycin, 100 μg/ml streptomycin, 10 μg/ml gentamicin, and/or 500 μM isopropyl-β-
Dthiogalactoside (IPTG, http://www.applichem.de). E. coli strains were cultivated in LuriaBertani liquid medium (LB) or on 
Luria-Bertani agar on plates (LA) at 37°C overnight. When indicated, media were supplemented with 50 μg/ml kanamycin, 
200 μg/ml ampicillin, 20 μg/ml gentamicin, 500 μM IPTG, and/or 1 mM diaminopimelic acid (DAP). 
 
Animal experimentation 
Animal handling was performed in accordance with the Swiss Animal Protection law and local animal welfare bodies. The 
animal experiments in this work were approved by the Veterinary Ofﬁce of the Canton Basel-Stadt (License number 1741). 
All animals were kept at SPF (speciﬁc pathogen-free) conditions. Animals were obtained from Janvier labs at the age of 8-10 
weeks. After two weeks of adaptation, rats were infected with bacteria harvested and diluted in phosphate-buffered saline 
(PBS) at OD595nm = 1. On anesthetized rats (1 – 3% isoflurane/O2 mixture), we performed either intradermal injection in the 
dermis of the ear (10 μl of the bacterial solution; inoculum 107 CFUs) or intradermal injection in the tail vein (200 μl of the 
bacterial solution; inoculum 2x108 CFUs). 
Blood samples were drawn and diluted (9:1) in PBS supplemented with 3.8 % of sodium-citrate, to prevent coagulation, and 
kept at -80°C for at least 1 hour. After thawing, blood samples were serial diluted in PBS and plated on appropriate agar plates 
(HIA plates). Then for counting, bacteria were incubated at 35°C and 5% CO2 for either 5-6 days for Btr or 10 days for B1-1C. 
 
Medium composition 
Media Composition Quantity (g) for 1L 
Tryptic Soy Agar (TSA) 
BDTM 
Pancreatic Digest of Casein 15.0 
Papaic Digest of Soybean Meal 5.0 
Sodium Chloride 5.0 
Agar 15.0 
   
Heart Infusion Agar (HIA) 
BDTM 
 
Beef Heart infusion from 500g 10.0 
Tryptose 10.0 
Sodium Chloride 5.0 
Agar 15.0 
   
Luria-Bertani Broth (LB) 
BDTM 
Tryptone 10.0 
Yeast extract 5.0 
NaCl 10.0 
   
Luria-Bertani Broth (LB) 
BDTM 
Tryptone 10.0 
Yeast extract 5.0 
NaCl 10.0 
Agar 15.0 
 
The powder mixed with 600 ml of ddH2O was autoclaved and supplemented with 4.2% (v/v) sterile defibrinated sheep’s 
blood  
TSA and HIA plates were supplemented with 5% of defibrinated sheep blood (Thermos FisherTM) 
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Generation of spontaneous streptomycin-resistant strains 
We generated the spontaneous streptomycin-resistant B1-1C mutant by spreading 100μl (OD595nm = 1) bacteria on TSA plates 
containing streptomycin at a concentration of 100 µg/ml. The rspL gene was amplified by colony-PCR primers prCB020 (Frw) 
and prCB021 (Rev) then sequenced with prCB020, prCB021 and prCB022.  Nucleotide sequence alignment allowed to isolate 
the streptomycin-resistant B1-1C strain (CB0126). Generation of the spontaneous streptomycin-resistant Btr strain RSE149 
(CB0165) has been previously described [9].  
Plasmid Construction 
All primers used for the elaboration of this report are listed in table. The suicide mutagenesis vector pTR1000 used for gene 
replacement in this study was described previously [36]. The vector pBZ485 was used as template for complementation. 
 
pCB001 used for generating the Bartonella 1-1C-gfp strain (CB0140) was constructed as follow. The 951-bp fragment gfp-
mut3 was amplified from pCD353#5 by using the oligonucleotide primers prCB013 and prCB014. The amplified product was 
digested with AvrII and PacI and cloned into the Tn mutagenesis vector pPE0012, digested with AvrII and PacI, to yield the 
gfp-transposon vector pCB001 
pTRΔflaA and pTRΔvirD4 were used to generate B1-1C ΔflaA SmR (CB0147) and B1-1C ΔvirD4 SmR (CB0151), respectively. 
Plasmid construction and gene replacement were already described [40]. 
The complementation vector pJK024 used for generating B1-1C ΔflaA pflA SmR (CB0139) was generated as follow. The flaA 
gene was amplified from CB0131 (B1-1C SmR) with the oligonucleotide primers prJK221 and prJK222.The 1800 bp-amplified 
product was digested with KpnI and BamH1 and cloned into the complementation plasmid pBZ485a, digested by KpnI and 
BamH1, to yield pJK024.  
The complementation vector pJK025 used for generating B1-1C ΔvirD4 pvirD4 SmR (CB0138) was generated as follow. The 
virD4 gene was amplified from B1-1C SmR (CB0131) with the oligonucleotide primers prJK223 and prJK224.The 2600 bp-
amplified product was digested with KpnI and BamH1 and cloned into the complementation plasmid pBZ485a, digested by 
KpnI and BamH1, to yield pJK025.  
pJK011 used for generating B11C Δbep1 in-frame mutant was generated as follows. The HR1, corresponding to the 1030 bp 
downstream bep1 locus, was amplified from B11C SmR (CB0131) with the oligonucleotide primers prJK113 and prJK115. The 
HR2, corresponding to the 1046 bp upstream bep1 locus, was amplified from B11C SmR (CB0131) with the oligonucleotide 
primers prJK114 and prJK116. The amplified products were merged by SOEing PCR with the oligonucleotide primers prJK113 
and prJK116. The 2076 bp-product was digested with BamH1 and XbaI and clones into the suicide vector pTR1000, digested 
with XbaI and BamH1, to yield pJK011. Insertion of the SOEing fused-product within pTR1000 was confirmed by PCR with the 
oligonucleotide primers prCB116 and prCB117 spanning the insertion site. 
 pJK012 used for generating B11C Δbep2 in-frame mutant was generated as follows. The HR1, corresponding to the 1053 bp 
downstream bep2 locus, was amplified from B11C SmR (CB0131) with the oligonucleotide primers prJK120 and prJK123. The 
HR2, corresponding to the 1136 bp upstream bep2 locus, was amplified from B11C SmR (CB0131) with the oligonucleotide 
primers prJK121 and prJK123. The amplified products were merged by SOEing PCR with the oligonucleotide primers prJK120 
and prJK123. The 2189 bp-product was digested with BamH1 and XbaI and clones into the suicide vector pTR1000, digested 
with XbaI and BamH1, to yield pJK012. Insertion of the SOEing fused-product within pTR1000 was confirmed by PCR with the 
oligonucleotide primers prCB116 and prCB117 spanning the insertion site. 
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pJK020 used for generating B11C Δbep10 in-frame mutant was generated as follows. The HR1, corresponding to the 1072 bp 
downstream bep10 locus, was amplified from B11C SmR (CB0131) with the oligonucleotide primers prJK192 and prJK193. The 
HR2, corresponding to the 1140 bp upstream bep10 locus, was amplified from B11C SmR (CB0131) with the oligonucleotide 
primers prJK194 and prJK195. The amplified products were merged by SOEing PCR with the oligonucleotide primers prJK192 
and prJK195. The 2212 bp-product was digested with BamH1 and XbaI and clones into the suicide vector pTR1000, digested 
with XbaI and BamH1, to yield pJK020. Insertion of the SOEing fused-product within pTR1000 was confirmed by PCR with the 
oligonucleotide primers prCB116 and prCB117 spanning the insertion site. 
Procedure for gene replacement and confirmation of the mutants 
Following the mobilization of the suicide mutagenesis vector into the appropriate Bartonella strain, kanamycin was used as 
a positively selection step to isolate cointegrates. Growing bacteria that integrated the suicide mutagenesis vector by 
homologous recombination were selected by colony PCR spanning the two homology regions with the appropriate 
oligonucleotide primers. Then, cointegrates were negatively selected on a media supplemented with streptomycin. The 
surviving bacteria have lost the mutagenesis vector by a second homologous recombination leading to two situations; either 
the clone harbor the in-frame deletion or the restoration of the wild type conformation. Colony PCR spanning the region of 
interest was performed to isolate clones carrying the deletion by comparing the size of the generated PCR products.  
 
Construction of GFP-expressing Bartonella 1-1C. 
The plasmid pCB001 containing a transposable kanamycin-gfp cassette, was introduced into B1-1C (CB0131) as a suicide 
vector via two-parental mating with JKE217 as the donor strain. Transconjugants displayed a light green colony phenotype. 
Twenty clones were harvested. FACS analysis of these clones confirmed GFP expression and 3 clones were intravenously 
injected in 3 rats. The clone triggering a similar bacteremia to B1-1C SmR (CB0131) was selected and used in all subsequent 
experiments reported in this study. Transposon insertion site was localized by semi-random PCR. 
 
Gentamicin protection assay 
Blood 100 μl of blood samples were withdrawn from infected rats with a syringe filled with 50 μl of PBS supplemented with 
3.8% of sodium citrate to prevent blood coagulation. To isolate erythrocytes from non-associated bacteria, the mixture was 
centrifuged at 500 g for 5 min. The pellet was resuspended in 100 μl of PBS and equally split into two tubes which were then 
centrifuged at 2100 g for 4 min. One pellet was resuspended in 50 μl of PBS supplemented with gentamicin sulfate (150 
μg/ml) while the other pellet was resuspensed in 50 μl of PBS. After 2 hours of incubation at 35°C, samples were washed 
three times in PBS to remove the antibiotic. In a final volume of 20 μl of PBS, samples were freezed at -80°C for at least 20 
min to release bacteria by hypotonic lyse of erythrocytes. After thawing, bacteria were serial diluted in PBS and plated onto 
HIA plates. Finally, bacteria were incubated at 35°C and 5% CO2 for either 5-6 days for Btr or 10 days for B1-1C before being 
counted. Results were annotated as CFU/ml of blood, where 1 ml of blood corresponds approximatively at 109 erythrocytes.  
 
Fluorescence Activated Cell Sorting (FACS) analysis 
Flow cytometry was used to assess the amount of GFP-expressing bacteria associated to erythrocytes. At day 11 post-
infection, blood samples were withdrawn from rat with a syringe filled with 50 μl of PBS supplemented with 3.8% of sodium 
citrate to prevent blood coagulation. On each blood sample was performed a 1:80 (12.5 μl) and a 1:500 (2 μl) dilution in 1ml 
of PBS. Then samples were analysed by flow cytometry and data for 106 events per sample were collected and analyzed. 
Data analysis 
Statistical analysis of the obtained data was performed using GraphPad Prism SoftwaRE. Depending on the experiment I used 
either the T-test or the two-way ANOVA to compare bacteremia curves. This information is indicated in the figure legends. P-
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valuet-test indicates the p-value calculated by the t-test and P-valueANOVA indicates the p-value calculated by the two-way 
ANOVA. 
   
Plasmid Genotype or relevant characteristics Reference 
 
pCD351 Contains the gfp-mut3 [9] 
pPE0012 Tn mutagenesis vector [59] 
pTR1000 Basic suicide mutagenesis vector for Bartonella [7] 
pBZ485a Plasmid used for complementation of B1-1C mutants Harms, A. 
pJK024.2.0. Encoding flaAB1-1C This study 
pJK025.2.0. Encoding virD4B11C This study 
pJK008 B sp. 1-1C Mtase [40] 
pTRΔflaA Suicide mutagenesis vector for flaA deletion in CB0126 [40] 
pTRΔvirD4 Suicide mutagenesis vector for virD4 deletion in CB0126 [40] 
 
 
Primers 
 
Sequence Reference 
prCB0113 ATGCTTAATTAAGGTTCTGGCAAATATTCTGA This study 
prCB0114 ATGTCCTAGGGCCTGCAGTTATTTGTATAG This study 
prJK113 GAGCGGGGATCCTTTCTCATTATTCATATTGCGG This study 
prJK114 TAGCTTGATACAATAACTATTTTTCTTCTTTCATTATTCTCTCCTTATAGTGTAAT This study 
prJK115 GAAAAATAGTTATTGTATCAAGCTAAAAATATG This study 
prJK116 GCCCTCGGATCCATGTATCTTAGAAACAGCAATCAGC This study 
prJK120 GAGCGGGGATCCTAAACTTAAATACAAACCGCTCATC This study 
prJK121 AATGGAAGAACACATTTTAACAAGCAAAATACACCTTTCCGTTTACAATAA This study 
prJK122 GCTTGTTAAAATGTGTTCTTCCA This study 
prJK123 GCCCTCGGATCCTTCGTTTGGAGAATGACATC This study 
prJK192 GAGCGGGGATCCAAGAACTAGGCTTATTAAGCACAAC This study 
prJK193 TATCGACATGATTCCTCCTCTAC This study 
prJK194 TCGTAGAGGAGGAATCATGTCGATAGCCAGTTAATGACGTAAACCTT This study 
prJK195 GCCCTCGGATCCTTAAAAACATTCAACAGCATGTC This study 
prJK221 GAGCGGGGATCCGCTGTTCCATTGCCTTTTAT This study 
prJK222 CTCCCGCGGTACCCTAATTACGAAACAAGGCTAAAATATT This study 
prJK223 GAGCGGGGATCCGAACGGATTATAAATTCTGCTAAA This study 
prJK224 CTCCCGCGGTACCTCAGTCTTTCTTTCCTTTGG This study 
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Strains 
 
Genotype or relevant characteristics 
 
Reference 
 
 
  
Bartonella 1-1C   
PEE0266 Wild Type [32] 
CB0131 Spontaneous SmR strain,  
Stocked after one passage in rat 
This study 
CB0140 Chromosomal integration of gfp, derivative of CB0131 Tn::5 
transposon integration 
This study 
CB0151 ΔvirD4, derivative of CB0131 [40] 
CB0138 ΔvirD4 pvirD4, derivative of CB0131 This study 
CB0350 ΔvirD4 revertant, derivative of CB0131 This study 
CB0147 ΔflaA, derivative of CB0131 [40] 
CB0139 ΔflaA pflaA, derivative of CB0131 This study 
CB0344 ΔflaA revertant, derivative of CB0131 This study 
CB0153 Δbep1, derivative of CB0131 This study 
CB0155 Δbep2, derivative of CB0131 This study 
CB0157 Δbep10, derivative of CB0131 This study 
CB0158 Δbep10 revertant, derivative of CB0131 This study 
  
Bartonella tribocorum  
RSE149 Spontaneous SmR strain, used as Btr WT in this study [9] 
   
Escherichia coli   
JKE217 MFDpri ΔT IV lacIq, harbor pJK008 
 
[40] 
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Discussion 
 
During the establishment of the infection model, our experiments revealed the requirement of a 
specific medium for reliable intradermal infection with B1-1C. Indeed, 3 days of growth on TSA medium 
were sufficient to trigger an infection rate of 100 % while 10 days were necessary for bacteria grown 
on HIA plates to display a similar rate. It is known that during the early stage of infection, lineage 4 and 
lineage 3 Bartonella species require the expression of the VirB/D4 T4SS to subvert host immune cell 
response and subsequently travel through the dermis and create an immune-silent environment in the 
lymphatic nodes [42]. Studies on B. henselae (Lineage 4) have shown that expression of the VirB/D4 
T4SS and its effector proteins are under the control of a dual activation of the BatR/BatS two-
component system (TCS) and the sigma factor RpoH1. On one hand, BatR/BatS is a pH sensor 
mechanism displaying an optimal activity at the physiological pH (7.4). On the other hand, RpoH1 
activation is modulated by the stringent response component SpoT and DksA involved in stress 
responses such as starvation. Therefore, we can assume that TSA medium induces a stringent response 
explaining why 3 days of growth is sufficient for reliable intradermal infection. Consistently, growing 
bacteria 10 days on HIA plates might decrease the nutrient availability over time impoverishing the 
environment and subsequently inducing a stringent response. It would explain the infection rate of 
100 % observed after 10 days of growth on HIA plates. However, since both media are considered as 
rich media for bacterial growth and both stabilize at a pH of 7.4 it is difficult to explain why TSA is more 
adapted. This kind of sensitivity, but less pronounced, for the growth media has also been reported in 
mice infections with Bartonella birtlesii. Indeed, mice develop bacteremia when intradermally infected 
with 102 CFUs of bacteria grown on TSA medium whereas 105 CFUs is the minimum inoculum to induce 
bacteremia when bacteria are grown on CBA medium (data not shown).  
Since we had now established appropriate conditions for in vivo infections with B1-1C, we compared 
its bacteremia to the lineage 4 strain B. tribocorum which provides most of our knowledge concerning 
the infection cycle of Bartonella spp. [6]. Comparison with Btr WT revealed a 9 days-delayed onset and 
a shorter bacteremia for B1-1C SmR (14 days instead of 64 days for Btr WT).  
Firstly, the 9 days delay observed for B1-1C can be explained by the different growth rate between B1-
1C and Btr. Indeed, independently of the growth media in vitro, it takes at least 5-6 days to observe 
B1-1C SmR colonies whereas 2-3 days are sufficient for Btr WT. It is known that during Bartonella 
infection, a large number of bacteria are simultaneously seeded from the lymphatic circulation into 
the bloodstream [42]. Even if the mechanism remains unknown, it is believed that Bartonella has to 
replicate until reaching a critical concentration inducing the release. Thus, we can assume that B1-1C 
requires more time to reach this critical concentration in comparison with Btr explaining the delay of 
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the bacteremia onset. As another hypothesis, B1-1C is not well adapted to rat resulting in an inefficient 
subversion of the immune response. Thus, B1-1C might require more time to travel through the dermis 
and reach the bloodstream (15-16 days) compared to other robust Bartonella models such as B. 
tribocorum, B. taylorii or B. birtlesii where the bacteremia appears 5-6 days post-inoculation [6, 8, 43]. 
Remarkably, we also reported for both strains a delayed onset for i.d. infection compared with i.v. 
infection. This delay could correspond to the time needed for Bartonella to travel from the inoculation 
site to the blood-seeding niche and conceivable interactions of Bartonella with the immune cells 
slowing down the progression through the dermis.  
  
Secondly, in addition to the delayed onset, another striking difference with Btr WT is the short 
bacteremia duration induced by B1-1C. Gentamicin protection assays and FACS analysis revealed that 
B1-1C is not intraerythrocytic which could justify this surprising bacteremia duration. Considering that 
erythrocytes colonization is a pivotal event for Bartonella pathogenicity by providing an immune-
privileged environment [42, 44], we can assume that B1-1C is no more protected against immune 
system and therefore is rapidly cleared from the blood explaining this short bacteremia duration. 
Interestingly, it has been reported that in an accidental host Bartonella can invade replicative niches 
such as DCs and  ECs but is unfit for establishing intraerythrocytic parasitism [45]. Interestingly, the B1-
1C strain used in our experiments was isolated in 1 out of 58 rats (R. norvegicus) tested by Lin et al. 
[32]. The small sample size of animals tested and the very low prevalence of B1-1C prevents any 
conclusion on R. norvegicus as the natural reservoir host of B1-1C [32]. Therefore, we cannot exclude 
that B1-1C was isolated from an accidental host explaining the extraerythrocytic localization reported 
in our rat infection. 
 
In lineage 4 species, host-specific adhesion to erythrocyte is mediated by the Trw T4SS [1, 24, 25]. Since 
in B. bacilliformis colonization of erythrocyte is flagella-dependent and lineage 3 species bear flagella 
instead of the Trw T4SS, we were interested in studying the role of the flagella during B1-1C infection. 
Therefore, rats were infected with either a flagellin-deficient strain B1-1C ΔflaA or a flaA trans-
complemented strain B1-1C ΔflaA pflaA or B1-1C ΔflaA revertant. To notice, FlaA protein (flagellin) is 
the main component of the filament and disruption of this gene prevents flagella assembly [35]. All 
strains have shown to be abacteremic preventing any conclusion concerning the role of the flagella 
during B1-1C infection. Furthermore, the abacteremic phenotype of the revertant strain indicates that 
genetic manipulation might have an impact on the fitness of the bacteria. Other B1-1C mutants were 
generated such as B1-1C ΔvirD4, B1-1C ΔvirD4 pvirD4, B1-1C ΔvirD4 revertant in order to study the role 
of the VirB/D4 T4SS during infection and B1-1C Δbep1, B1-1C Δbep2, B1-1C Δbep10 and B1-1C Δbep10 
revertant strain to clarify the role of lineage 3-Beps during infection. Remarkably, similarly to flaA 
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mutants, all were abactermic (Unpublished data) supporting the hypothesis that there is an 
attenuation of bacterial fitness associated with genetic manipulations or/and successive in-vitro 
passages. 
Attenuation of the ability to infect laboratory animals after successive in vitro passages or gene 
manipulation has been reported in the literature for different species such as Borrelia burgdorferi or 
Mycobacterium tuberculosis. B. burgdorferi lost its ability to colonize laboratory animals after 10 in 
vitro passages and the virulent M. tuberculosis strain H37Rv was no longer virulent for common 
laboratory animals after numerous in vitro passages [46-48]. Another striking example of infectivity 
attenuation associated with in vitro passages is the use of this technic to attenuate pathogens to in 
fine produce vaccines or safe laboratory model pathogens [49-51].  
Concerning Bartonella spp., the loss of the virulence factor BadA, a trimeric autotransporter adhesin, 
has been reported for B. henselae after numerous in vitro passages disturbing the capacity of the 
bacteria to successfully infect its host [52]. Of note, Bartonella spp. are fastidious bacteria with a very 
weak in vitro growth rate. Bartonella 1-1C is no exception to the rule and any genetic engineering 
requires several in vitro passages added to long growth time on plate. Taken together, we can assume 
that recurrent genetic manipulations on B1-1C and/or successive in vitro passages attenuate the 
infectivity of the original strain explaining the abacteremic phenotype reported for all B1-1C mutant 
strains.  
Since we assume that genetic engineering and/or in vitro passages attenuate bacterial infectivity it was 
surprising to observe no significant difference between bacteremia curves induced by B1-1 WT and 
B1-1C SmR.  Even if antibiotic resistance acquisition is frequently associated with a fitness cost [53-55], 
it has been reported that the fitness cost of resistance acquisition such as streptomycin can be 
compensated by a secondary mutation [56-58]. Therefore, it could explain the similarity between 
bacteremia triggered by B1-1C WT and the streptomycin resistant strain. Furthermore, acquisition of 
a streptomycin resistant strain requires only one supplementary in vitro passage, which might be 
insufficient to induce infectivity attenuation. Furthermore, the chromosomic insertion of a transposon 
harboring a gfp cassette within Bartonella 1-1C has a weak impact on the bacterial fitness. 
Transposition is a genetic technique where a transposable element is inserted within the genome and 
requires only a few in vitro passages. 
 
Taken together, all the findings concerning B1-1C compared to what is known about Bartonella 
infection, drove us to reconsider the rat as the natural specific host of B1-1C. Indeed, this would explain 
why (i) B1-1C is unable to colonize rat’s erythrocytes in our experiments, which has a pivotal role in 
Bartonella pathogenicity; (ii) that genetic engineering and/or successive in vitro passages have a strong 
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impact on the infectivity; (iii) the high sensitivity for the growth media for reliable infection; and (iv) 
the long-time needed to B1-1C to travel through the dermis from the inoculation site to the 
bloodstream likely due to the lack of appropriate and specific tools to subvert host immune cells.  
Nevertheless, if we assume that the rat is not the natural host of B1-1C, the real natural host might be 
evolutionary closed to Rattus norvegicus explaining why B1-1C is able to trigger a short infection of the 
host similarly to BAR15 that induces bacteremia in rat while it is a red squirrel specific pathogen [12].  
 
In summary, in this study we have developed an in vivo infection model in rat for lineage 3 Bartonella 
species. By using i.d. and i.v. infections with B1-1C we reveal a delayed and shorter bacteremia kinetic 
compared to the lineage 4. The major finding of this study is the inability of B1-1C to colonize 
erythrocytes which rise to question the specific relation between rat and this Bartonella species.  
 
To provide more significance to our in vivo results such as the non-intraerythrocytic life style and to 
confirm our genetic engineering it seems crucial to establish an in vitro infection model. Finally, we 
have to keep in mind that lineage 3 species could use a different infection strategy compared to other 
lineages and it needs further investigation on bacteremia kinetic of other lineage 3 species such as B. 
clarridgeiae or B. AR15-3. Therefore, if the extraerythrocytic life style of B 1-1C is confirmed, the 
murine model described in this study should provide an experimental basis for further investigations 
on lineage 3 and hasten our understanding of Bartonella infection strategies. 
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Abstract 
 
Many bacterial pathogens translocate through their membrane numerous effectors to subvert host 
cellular signaling pathways. These effectors often act in concert to efficiently infect the host. The α-
proteobacterial genus Bartonella uses a VirB/D4 Type 4 secretion system (T4SS) to translocate a set of 
Bartonella effector proteins (Beps) into targeted host cells. The significance of the VirB/D4 T4SS for 
Bartonella pathogenicity has been shown previously but, up to date, the role of the effectors was 
extensively studied in vitro but not in vivo.  
Therefore, in this study we investigated the contribution of the Bartonella VirB/D4 T4SS and its 
translocated proteins during in vivo infection process. To do so, we used the rat-specific Bartonella 
tribocorum (Btr) infection model. Our investigations highlighted a bacteremic phenotype of the Bep-
deficient Btr ΔbepA-I mutant characterized by a bacteremia with a shorter duration and a delayed 
onset compared to Btr WT.  This fitness lost was increased at low inoculum (105 CFUs/ml) where the 
Btr ΔbepA-I was unable to trigger bacteremia whereas the WT strain was still infectious. Even though 
this phenotype was inoculum-dependent, the ability of the Bep-deficient Btr to cause bacteremia 
whereas a VirB/D4 T4SS-deficient strain was abacteremic raised questions on the central role of the 
Beps. The phylogenetic analysis of Bartonella species suggested the translocation of an additional 
effector named YopJ via the VirB/D4 T4SS. Previously described as a Type 3 secretion effector in 
Yersinia pestis, our results suggest YopJ to have evolved as a Type 4 secretion effector in Bartonella 
species. We also showed that a single yopJ was independently acquired by the last common ancestors 
of lineage 3 and lineage 4, two lineages bearing the VirB/D4 T4SS, and evolved in several Bartonella 
species via parallel rounds of gene duplication and differentiation events. Finally, the decreased 
bacterial fitness of Btr ΔyopJ and Btr ΔbepA-I ΔyopJ strains in rat infection model confirmed the 
implication of YopJ in Bartonella pathogenesis. 
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Introduction 
 
During evolution, pathogenic bacteria have developed a wide variety of highly specialized virulence 
factors. Secretion of proteins via macromolecular nanomachine is one strategy shared by many 
bacteria in order to subvert immune signaling pathways of the host [1]. Depending on their structures, 
secretion mechanism and specificity, translocation apparatus can be categorized into different classes 
from type 1 to type 9 secretion systems [2]. Among Gram-negative and Gram-positive bacteria, the 
type IV secretion systems are extensively spread. The number of bacteria using these systems during 
infection process continues to expand and includes some clinically-important human pathogens such 
as Helicobacter pylori, Legionella pneumophila, Bordetella pertussis, Brucella and Bartonella species 
[3-5]. One striking example of host signaling pathway subversion is the translocation of CagA by 
Helicobacter pylori T4SS. This effector disturbs both innate and adaptive immune responses of the host 
allowing H. pylori to infect the mucous membrane of the human stomach [6].  
The facultative intracellular α-proteobacterial genus Bartonella comprises arthropod-borne Gram-
negative bacteria that typically cause a long-lasting intraerythrocytic infection in their specific 
mammalian host. Based on phylogenetic analysis and properties of the virulence factors, Bartonella 
genus is divides into four different lineages named lineage 1 to 4. Bartonella infection cycle is 
characterized by the infection of two distinctive niches: the dermal niche and the blood seeding niche. 
Following the dermal inoculation via a blood sucking arthropod, Bartonella invades the dermal niche 
characterized by the colonization of dendritic cells and the lymphatic circulation [7, 8]. Then, Bartonella 
is released into the bloodstream where it infects endothelial cells and erythrocytes. Within red blood 
cells bacteria undergo few rounds of replication before staying in a non-dividing state for the remaining 
life time of the red blood cells [8, 9]. Thus, Bartonella can be ingested during the arthropod blood-meal 
and subsequently being transmitted to another host. 
In the Bartonella genus, translocation of Bartonella effector proteins (Beps) via the VirB/D4 T4SS has 
been identified as a critical virulence mechanism for a successful infection [1, 10]. Horizontal 
acquisition in lineage 3, lineage 4 and in B. ancashensis of the same virB/D4 T4SS locus with a single 
ancestral effector has occurred during three independent events, which were followed by 
chromosomal integration [11-14]. The parallel evolution of these sets of effectors, driven by the 
pathoadaptation to the host, led to the emergence of three distinct arsenals resulting in a high ability 
to infect a broad spectrum of mammalian hosts [11, 15, 16]. Despite the radiative evolution and 
diversification, a bipartite signal consisting of a C-terminal Bep-intracellular delivery (BID) domain and 
a positively charged C-tail is shared by all the Beps [17, 18]. It is believed that a primordial effector 
acquired this bipartite signal to promote translocation by the VirB/D4 T4SS into the targeted cell. 
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Moreover, it has been also revealed that the BID domain can interfere with host signaling pathways 
[7, 19]. In addition to the bipartite signal, around 70% of all of the Beps in the Bartonella genus display 
a N-terminal filamentous induced cAMP (Fic) domain shown to promote post-transcriptional 
modification such as AMPylation, phosphorylation or phosphocholination [20-22]. The other Beps, 
lacking the Fic domain, bear instead additional BID domains or/and tandem-repeated tyrosine (pY)-
motifs [17].  
Previously, the role of Bartonella effector translocation in vivo was analyzed via intravenous infection 
of rats with either Btr ΔvirD4 or Btr ΔvirB4. The VirB4 ATPase, located in the cytoplasmic side, is a 
crucial component of the VirB/D4 T4SS that provides energy for pilus biogenesis and effector 
translocation. Therefore, Btr ΔvirB4 does not express a functional translocation machinery [23, 24]. 
Unlike VirB4, the coupling protein VirD4 is involved exclusively in effector translocation by recognizing 
the bipartite T4S signal harbored by effectors and by providing energy for the process [24]. Therefore, 
Btr ΔvirD4 expresses a machinery that lacks the ability to recruit and translocate effectors.  Rats 
infected with Btr ΔvirD4 or Btr ΔvirB4 did not develop bacteremia indicating the dependency of 
Bartonella on the VirB/D4 T4SS and on the effector translocation process to establish bacteremia [25].  
 
In this study, we showed a bacteremic phenotype of a Bartonella tribocorum strain deficient for all 
Beps questioning the significance of the Beps during the infection process. Furthermore, genetic 
analysis performed in this study revealed the presence of another effector widely distributed among 
Bartonella species harboring the VirB/D4 T4SS: a YopJ-like effector. The YopJ effector has been 
previously characterized as a Type 3 secretion effector (T3SE) in Yersinia pestis. Interestingly, our 
researches suggest that YopJ evolved as a T4S effector in Bartonella species.  
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Results 
 
Protein translocation by the virB/D4 T4SS is a crucial process for Bartonella to establish a successful 
infection bacteremia. Previous work showed that Bartonella loses its infectivity when we prevent 
either the assembly of the virB/D4 T4SS (Btr ΔvirB4) or the translocation by the coupling protein (Btr 
ΔvirD4) [25]. To analyze the role of the virB/D4 T4SS and the Beps during infection at the molecular 
level, I generated a Bep free mutant, Btr ΔbepA-I, and compared it to Btr WT. Furthermore, rats were 
infected via two different infection routes in order to have a more precise overview at which stage of 
the infection the VirB/D4 T4SS and the Beps could play a role. The intradermal infection route (i.d.) 
mimics the natural way of infection whereas the intravenous route (i.v.) bypasses the first dermal stage 
of the infection.  
 
Btr ΔbepA-I triggers impaired bacteremia after i.d. injections  
 
The goal in first step was to compare bacteremia kinetics induced by Btr WT (Fig. 1A) and Btr ΔbepA-I 
(Fig. 1B) via intradermal route. 
Compared to Btr WT, Btr ΔbepA-I showed bacteremia impairments indicating a fitness decrease. 
Indeed, in the group of rats infected with Btr ΔbepA-I, bacteremia onset and duration were significantly 
different from Btr WT (p-value = 0.0015 and 0.0001, respectively) (Fig. 1C). Taken together, these 
results indicate that Beps facilitate bacteremia establishment and maintain a long-lasting infection. 
Moreover, the infection rate of Btr ΔbepA-I was 60% whereas the infection rate of Btr WT was 100% 
confirming a fitness loss for the Bep-free mutant. However, the fact that the maximum titer reached 
by bacteremia was not significantly different from Btr WT (p-value = 0.4879) indicates that Beps are 
not involved in bacterial replication during the infection process (Fig. 1C). Remarkably, rat #849 (Fig. 
1A) and rat #1023 (Fig. 1B) showed defective bacteremia curves. We assume that Bartonella faced a 
strong immune response making the infection more challenging in these infected rats.  
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Figure 1. Bacteremia analysis in rats intradermally infected with Btr WT and Btr ΔbepA-I 
Bacteria were grown for 3 days at 35°C and 5% CO2 on Heart Infusion Agar (HIA) plates supplemented with defibrinated 
sheep blood. Plotted graphs represent time course of single animals (indicated by the different animal numbers) from which 
bacteria were recovered at a given time point post-infection. Each value corresponds to an average (CFU/ml of ml of blood) 
acquired from serial dilutions. Each color shade represents a cohort of animal infected the same day with bacteria from the 
same bacterial solution. Tables correspond to the mean ± SD of the onset, duration and maximum titer between all 
bacteremia of the associated graph. The infection rate is also indicated (A) Groups of 10 weeks old Wistar rats (107 CFUs, n 
= 11) were intradermally infected with Btr WT. (B) Groups of 10 weeks old Wistar rats were intradermally infected (107 CFUs, 
n = 10) with Btr ΔbepA-I.  (C) A statistical t-test analysis between the two strains was performed on bacteremia onset, 
duration and maximum titer.  
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Btr ΔbepA-I triggers impaired bacteremia after i.v. injections  
 
Since we observed a fitness loss in i.d. injections, we were interested to determine if there is also a 
fitness decrease after intravenous infection. Therefore, we infected rats with either Btr WT (Fig. 2A) or 
Btr ΔbepA-I (Fig. 2B) strain via intravenous route.  
Similarly to i.d. infection, rats intravenously infected with Btr WT developed impaired bacteremia with 
a delayed onset and a shorter duration statistically different from Btr WT (p-value = 0.0021 and 0.0002, 
respectively) (Fig. 2C). Furthermore, we observed that Btr ΔbepA-I displayed an infection rate of 83% 
instead of 100% for Btr WT. No significant difference was observed for the maximum titer reached by 
the bacteremia (Fig. 2C). Therefore, consistently to i.d. infection, these observations indicate that (i) 
Beps are not crucial but facilitate bacteremia establishment and maintain a sustainable bacteremia 
and, (ii) Beps are not involved in bacterial replication during the infection.  
Remarkably, rats #1046 and #1047 (Fig. 2A, blue lines) showed an unusual high titer (reached 107 
CFUs/ml) and a longer duration (75 days). Interestingly, these two rats belonged to the same cohort 
of animal. Therefore, we suggested that these rats must have had a weaker immune system to face 
the bacteria and subsequently to clear the infection. To notice, we termed cohort rats belonging to the 
same animal order.  
Furthermore, when we compared the two routes of infection for either Btr WT or Btr ΔbepA-I, we 
detected a delayed onset after i.d. injections, which might correspond to the time needed for the 
bacteria to travel from the dermis to the bloodstream. 
Taken together, even if the bep-free mutant is still bacteremic, these results clearly showed a loss of 
infection fitness of Btr ΔbepA-I compared to Btr WT. However, compared to the natural condition, the 
high inoculum used for infection is not relevant and could have an effect on Bartonella infection in 
vivo. To assess this hypothesis, we decided to test lower inocula. 
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Figure 2. Bacteremia analysis in rats intravenously infected with Btr WT and Btr ΔbepA-I 
Bacteria were grown for 3 days at 35°C and 5% CO2 on Heart Infusion Agar (HIA) plates supplemented with defibrinated 
sheep blood. Plotted graphs represent time course of single animals (indicated by the different animal numbers) from which 
bacteria were recovered at a given time point post-infection. Each value corresponds to an average (CFU/ml of ml of blood) 
acquired from serial dilutions. Each color shade represents a cohort of animal infected the same day with bacteria from the 
same bacterial solution. Tables correspond to the mean ± SD of the onset, duration and maximum titer between all 
bacteremia of the associated graph. The infection rate is also indicated (A) Groups of 10 weeks old Wistar rats (107 CFUs, n 
= 9) were intravenously infected with Btr WT. (B) Groups of 10 weeks old Wistar rats were intravenously infected (107 CFUs, 
n = 6) with Btr ΔbepA-I.  (C) A statistical t-test analysis between the two strains was performed on bacteremia onset, duration 
and maximum titer.  
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Btr ΔbepA-I bacterial fitness is dose-dependent  
 
In the wild, the amount of bacteria needed to establish bacteremia is hardly assessable but probably 
is significantly lower than the dose used in laboratory (107 CFUs for i.d.). The high dose used could 
explain the infectivity of Btr ΔbepA-I and to assess this hypothesis, we decided to infect rats with lower 
inocula, 105 and 102 bacteria, and to compare with bacteremia kinetics observed with the inocula 107 
bacteria.  
 
Groups of rats were infected with different doses of Btr WT and bacteremia was monitored and 
compared (Fig. 3A). We observed a correlation between the inoculum and bacterial fitness: with lower 
inoculum, bacteremia appearance was delayed and bacteremia duration was shorter. We also noticed 
that with an inoculum of 102 bacteria the infection rate dropped to 33% instead of 100% for the two 
others. This suggests that in natural conditions the amount of Bartonella for a successful infection 
probably has to be above a certain threshold comprised between 102 and 105 CFUs. Interestingly, in all 
the conditions tested, bacteremia reached a maximum titer of around 106 CFUs/ml implying that the 
bacteremia titer was not dose-dependent and that following an unknown mechanism, Bartonella were 
released synchronously in the bloodstream after several rounds of replication in an undefined 
replicative niche. 
 
Groups of rats were infected with different doses of Btr ΔbepA-I and bacteremia was monitored and 
compared (Fig. 3B). We also observed a correlation between the inoculum and bacterial fitness but 
with a more pronounced phenotype compared to Btr WT.  Indeed, infection rates dropped to 0% for 
105 and 102 CFUs instead of 100% for 107 CFUs. Compared to Btr WT, results clearly showed for a 
decrease in Btr ΔbepA-I fitness represented by a shift to the right of the infective dose 50 (ID50) (Fig. 
3C). ID50 corresponds to the estimated number of pathogens required to produce an infection in 50% 
of the animals exposed to the pathogen by a given route. Thus, in our experiment, a higher number of 
Btr ΔbepA-I has to be injected compared to Btr WT to establish successful bacteremia, showing that 
the bacteremic phenotype of Btr ΔbepA-I is dose-dependent. 
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Figure 3: Bacterial fitness of Btr WT and Btr ΔbepA-I decreases with low inoculum   
Bacteria were grown for 3 days at 35°C and 5% CO2 on Heart Infusion Agar (HIA) plates supplemented with 
defibrinated sheep blood. Plotted graphs represent an average CFU/ml of blood in animal groups from which 
bacteria were recovered at a given time point post-infection. (A) Groups of 10 weeks old Wistar rats (n = 3 for 
each inoculum) were intradermally infected in the ear with 107, 105 or 102 CFUs of Btr WT. To notice, only one rat 
was bacteremic for the inoculum 102 CFUs. (B) Groups of 10 weeks old Wistar rats (n = 3 for each inoculum) were 
intradermally infected in the ear with 107, 105 or 102 CFUs of Btr bepA-I. (C) Graph representing the infective dose 
curves for Btr WT (black line) and Btr ΔbepA-I (red line). ID50 correspond to the number of bacteria required to 
induce bacteremia in 50% of infected rats. As result, we observed a shift to the right of Btr ΔbepA-I curve meaning 
a higher dose of bacteria is needed to trigger bacteremia in 50% of infected rats.  
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 A functional VirB/D4 T4SS is crucial for bacteremia establishment 
 
The abacteremic phenotype of Btr ΔvirD4 and Btr ΔvirB4 previously described in the literature 
suggested a key role of Beps translocation by the VirB/D4 T4SS to establish successful bacteremia [25]. 
However, the Btr ΔbepA-I bacteremic phenotype we obtained at high inoculum contrast with the 
essential trait of Beps during infection. To further characterize the role of the VirB/D4 T4SS and Beps 
during infection, we generated two mutants: Btr ΔbepA-I ΔvirD4 and Btr ΔbepA-I ΔvirD4 ΔvirB. By 
infecting rats with these mutants, we aimed to answer multiple questions: (i) Is there a toxic 
accumulation of Beps within Btr ΔvirD4 explaining its abacteremic phenotype? (ii) Has the T4SS a 
pathogenic effect on its own?  (iii) Does the T4SS translocate proteins different from Beps?  
 
To elucidate the significance of the VirB/D4 T4SS during Btr infection, we first tried to reproduce the 
results published by Schulein et al.  by infecting intradermally and intravenously rats with Btr ΔvirD4 
(Fig. 4A) [25]. The strain appeared abacteremic with both infection routes (i.d. and i.v.), as previously 
described, implying that translocation mediated by the coupling protein VirD4 is crucial for bacteremia 
establishment. To exclude any polar effect of the deletion, we also infected intradermally rats with the 
complemented strain Btr ΔvirD4 pvirD4 (Fig. 4B). By expressing in-trans virD4, the WT phenotype was 
restored concerning bacteremia duration and titer but with a short delay in bacteremia onset (14 d.p.i.) 
compared to Btr WT (8 d.p.i.) (Fig. 1A). Considering that Btr ΔbepA-I was still bacteremic, could the 
abacteremic phenotype of Btr ΔvirD4 be due to a toxic accumulation of Beps? 
To determine if a toxic accumulation of Beps could explain the abacteremic phenotype of Btr ΔvirD4, 
we generated a strain deficient for VirD4 and the Beps by removing virD4 in a Bep-free Btr strain: Btr 
ΔbepA-I ΔvirD4. Therefore, we infected rats with this strain via both i.d. and i.v. routes. Then 
bacteremia kinetic was monitored by sampling over time the blood of infected rats (Fig. 4C). We 
observed that Btr ΔbepA-I ΔvirD4 was abacteremic excluding the assumption of a toxic effect of an 
accumulation in Btr ΔvirD4. Furthermore, since Btr ΔbepA-I ΔvirD4 still express the T4S machinery, we 
can assume that the VirB/D4 T4SS did not trigger any pathogenic effect on its own. 
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Figure 4: Bacteremia analysis in rats intradermally infected with Btr ΔvirD4, Btr ΔvirD4 pvirD4, Btr ΔbepA-I ΔvirD4 and  
Btr ΔbepA-I ΔvirD4 ΔvirB.  
Bacteria were grown for 3 days at 35°C and 5% CO2 on Heart Infusion Agar (HIA) plates supplemented with defibrinated 
sheep blood. Plotted graphs represent time course of single animals (indicated by the different animal numbers) from which 
bacteria were recovered at a given time point post-infection. Each value corresponds to an average (CFU/ml of blood) 
acquired from serial dilutions. (A) Groups of 10 weeks old Wistar rats were intradermally (inoculum 1x107 CFUs, n = 2, filled 
symbols) or intravenously (inoculum 2x108 CFUs, n = 2, unfilled symbols) infected with Btr ΔvirD4. (B) One 10 weeks old 
Wistar rats was intradermally (inoculum 107 CFUs, n = 2) infected Btr ΔvirD4 pvirD4. (C) Groups of 10 weeks old Wistar rats 
were intradermally (107 CFUs, n = 3, filled symbols) or intravenously (inoculum 2x108 CFUs, n = 3, unfilled symbols) infected 
with Btr ΔbepA-I ΔvirD4. (D) Groups of 10 weeks old Wistar rats were intradermally (inoculum 107 CFUs, n = 3, filled symbols) 
or intravenously (inoculum 2x108 CFUs, n = 3, unfilled symbols) infected with Btr ΔbepA-I ΔvirD4 virB.  
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To clarify the role of the VirB/D4 T4SS and its Beps during Btr infection, we decided to generate Btr 
ΔbepA-I ΔvirD4 ΔvirB. To generate this strain, we did a one-step deletion of 20 kb including the virB 
locus, the bep locus, and the coupling protein virD4. In Btr genome, these loci are successive to each 
other, making this one-step deletion feasible. Then we studied bacteremia kinetic by infecting rats via 
i.d. and i.v. routes (Fig. 4D). In both conditions, we did not observe bacteremia confirming that the T4S 
machinery, with its associated coupling protein VirD4, is crucial for Btr to establish infection. In 
combination with the bacteremic phenotype of Btr ΔbepA-I, these results indicate the translocation of 
unknown substrate(s) by Btr to establish a successful infection. 
 
 YopJ: a novel putative VirB/D4 Type 4 effector protein 
 
To subvert eukaryotic signaling pathway, Y. pestis translocates six type 3 secretion effectors (T3SEs), 
including YopJ, that are part of the Yop virulon encoded on a 70-kb plasmid named pCD [26]. The T3SE 
YopJ is an acetyltransferase targeting the Mitogen-activated protein kinase (MAPK) and the nuclear 
factor κB (NFκB) signaling pathways involved in the innate immune response [27].  The 288 amino acid 
YopJ protein is divided into three regions: The N-terminal domain carrying the T3S signal, a central 
region harboring a catalytic triad and the C-terminal domain regulating effector activity. The catalytic 
triad of YopJ is formed by 3 amino acids: His109, Glu128 and Cys172 [28]. In a previous study, the presence 
of YopJ in Bartonella quitana species has been revealed [29]. Therefore, we wanted to analyze the 
prevalence of YopJ among Bartonella spp. and more specifically within Btr.  
Lineage-specific acquisition of yopJ 
In order to evaluate the occurrence of YopJ among Bartonella spp., we decided to blast the amino acid 
sequence of the well-described YopJ of Yersinia pestis with Bartonella genus (Protein BLAST) [30]. We 
noticed that YopJ was well-represented among Bartonella spp. but only in lineage 3 and lineage 4, two 
lineages expressing the VirB/D4 Type 4 machinery (Fig. 5). In contrast, B. ancashensis (lineage 1) also 
carries a VirB/D4 T4SS, but no YopJ protein was detected. Two hypotheses could be made of it: B. 
ancashensis may have lost YopJ during evolution or may simply never acquired the protein. 
Furthermore, we found that the number of yopJ varied between one to three homologous genes 
depending on the lineage 3 and lineage 4 Bartonella species. Concerning our strain of interest, B. 
tribocorum had three copies of yopJ. Interestingly, some lineage 4 Bartonella spp. did not possess yopJ 
such as B. henselae and B. koehlerae (lineage 4). It could be that they lost the protein during evolution. 
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Since YopJ was widely distributed among lineage 3 and lineage 4 Bartonella spp., we were interested 
in studying the genomic localization of yopJ. The mapping of yopJ loci in Btr (lineage 4) and B1-1C 
(lineage 3) genomes indicated that they were not situated in a similar genomic region in both lineages 
(Fig. 6A). Furthermore, in silico analysis on Bartonella sequenced-species by using Geneious v.9.1.5 
allowed the establishment of a preliminary yopJ synteny for lineage 4 and lineage 3 (Fig. 6B and C). 
Interestingly, we noticed that the yopJ synteny was conserved and specific for the two lineages. In 
lineage 4 species yopJ homologous gene(s) were localized in one locus and always nearby groL, fumC, 
a gene encoding for a lysozyme and other uncharacterized genes sharing more than 80% of identity 
(dashed lines). However, in B. quintana, B. vinsonii and B. taylorii we did not detect groL and fumC. For 
B. taylorii this could be explained by the fact that this species is not fully sequenced so far. In B. 
quintana and B. vinsonii, these two genes were identified in another locus resulting from presumable 
genomic rearrangements. In lineage 3 species, three yopJ genes were found in two different loci where 
yopJ1 and yopJ2 were conserved on the same locus and yopJ3 was isolated on a different one.  
 
 
Figure 5. YopJ proteins are widely represented in Bartonella species harboring the VirB/D4 T4SS  
Phylogeny of the genus Bartonella with (a) candidatus tokpelaia hoelldoblerii as outgroup taxon. The phylogenetic tree 
was based on analysis of concatenated alignment of 5 core protein sequences. Three Bartonella clades have been 
identified: B. apis (green), B. tamiae (yellow) and eubartonellae. Eubartonellea are further classified into 4 lineages (shades 
of orange/pink). The presence or absence of the virulence factors are reported by full or empty circles, respectively. Values 
above branches show bootstrap support values (≥70%). Taken from Segers et al. 2017. ISME journal 
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Figure 6. yopJ was acquired independently in lineage 3 and lineage 4 Bartonella species and evolved via parallel 
duplication and diversification events 
(A) Genome maps of Btr. and B1-1C. (B) Synteny of yopJ genes in lineage 4 sequences species. (C) Synteny of yopJ genes 
in lineage 3 sequences species. Numbers in brackets correspond to the number of yopJ harbored by the species  (D) 
Percentage of identity between YopJs from Btr. 
1 kb 
Legend: 
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The fact that there was a conserved lineage-specific synteny indicated that yopJ was independently 
acquired by the last common ancestors of lineage 3 and lineage 4. This assumption was supported by 
the fact that lineage 1 and lineage 2 were lacking yopJ and by the different localization of yopJ loci 
between lineages (Fig 5 and 6A).  
Remarkably, in lineage 3 a bep identified as bep2 was flanked by yopJ1 and yopJ2. Since bep2 is 
assumed to be a duplication of bep1 in Bartonella spp., it is unlikely that yopJ and bep were acquired 
together (Fig. 6C). However, we cannot exclude that bep2 was displaced downstream to yopJ1 by 
genomic rearrangement and might act subsequently as a functional unit. This assumption could be 
supported by the fact that in B. AR 15-3 yopJ1 and bep2 were missing. 
Furthermore, in silico analysis using BLAST implemented in Geneious v.9.1.5 with the amino acid query 
sequences of YopJ from Bartonella sequenced-species permitted to set up a phylogenetic tree of YopJ 
from lineage3 and lineage 4 Bartonella species (Fig.7). The main finding was the clear separation 
between lineage 3 and lineage 4 YopJ proteins supporting the assumption that yopJ was acquired 
independently in the last common ancestors of each lineage and was followed by duplication and 
diversifications. Furthermore, the fact that all lineage 3 species displayed the same number of yopJ 
genes with conserved synteny indicates that these events occurred in the common ancestor prior 
speciation. On the contrary, lineage 4 species possessed one to three copies suggesting that the 
duplication events occurred after speciation.  
Indeed, since for B. washoeensis YopJ2 was not clustered with other YopJ2 we assumed an 
independent duplication of yopJ1. Furthermore, based on the phylogenetic tree established by A. 
Segers et al. [31]  we know that B. tribocorum, B. grahamii and B. rattumassiliensis are closely related 
(Fig. 5). In our phylogenetic tree YopJ2 of these species were grouped. Therefore, we can suppose that 
the duplication of yopJ1 occurred in the common ancestor of these three Bartonella species. However, 
we have to be careful with this assumption since B. elizabethae, which is also suggested to be closely 
related to these three species, carried only one yopJ. It is possible that (i) this species lost yopJ2 or, (ii) 
within the three others closely related Bartonella species yopJ1 was duplicated independently.  
Finally, B. tribocorum is so far the only known species bearing three yopJ homologous genes. Amino 
acid sequences alignment of the three YopJs of Btr with Geneious v.9.1.5. shown 83.90% identity 
between YopJ2 and YopJ3 and 58.50% and 58.90% with YopJ1, respectively (Fig. 6D). Furthermore, in 
the phylogenetic tree YopJ2 is closely related to YopJ3. Therefore, we believe that yopJ2 appeared 
after a first duplication event of yopJ1, and a more recent second duplication event of yopJ2 gave rise 
to the appearance of yopJ3. 
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Figure 8. YopJ alignment shows the conservation of the catalytic triad among lineage 3 and lineage 4 Bartonella spp. 
Comparison of YopJ sequences from Bartonella species and three Yersinia species (First 3 lines). Colored arrows above the alignment 
point to amino acids involved in the catalytic triad: His109 (orange arrow), Glu128 (purple arrow) and Cys172+ (yellow arrow). As result, 
this alignment highlighted that the triad is well conserved among Yersinia spp and Bartonella spp.  
Figure 7: Phylogenetic distribution of YopJ proteins among Bartonella species  
Phylogeny of YopJ proteins among the genus Bartonella with YopJ of Y. pestis as outgroup taxon 
(black). YopJ1 distribution is showed in blue. YopJ2 and YopJ3 distribution is showed in orange and 
green, respectively. Values above branches show bootstrap support values (≥70%).  
Histidine / His / H Glutamic acid / Glu / E Cysteine / Cys / C 
Lineage 4 
Lineage 3 
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The catalytic triad of YopJ is well conserved in Bartonella species 
In our in silico analysis, we observed that Bartonella spp. could have different yopJ copies called YopJ1, 
YopJ2, and YopJ3 (Fig. 6B). Although yopJ genes within Bartonella species undergone duplication and 
differentiation events we noticed in our amino acid sequences alignment the conservation of the 
catalytic triad (His/Glu/Cys - colored arrows) (Fig. 8). In Y. pestis, this catalytic triad is crucial for the 
protein activity with an acetyltransferase activity allocated to the cysteine[32]. 
Based on our in silico analysis and on the bacteremic phenotype of Btr. ΔbepA-I, we aimed to examine 
if YopJ plays a role in Btr infection. 
 
Btr ΔyopJ shows a bacterial fitness similar to Btr ΔbepA-I  
To elucidate the role of YopJ proteins during Btr in vivo infection, we generated a strain where we 
removed the three yopJ genes present in Btr. For this purpose, we deleted by a one-step in frame 
deletion the three genes in the Btr WT genome. The generated strain, Btr ΔyopJ, was then 
intradermally injected in rats (Fig. 9).  We observed that the bacteremia kinetic induced by Btr ΔyopJ 
was significantly different from Btr WT with a shorter duration and an lower titer indicating that YopJ 
effectors might contribute in Btr pathogeneicity. 
  
Btr ΔbepA-I ΔyopJ loses its infectivity  
We showed that Btr ΔbepA-I was still bacteremic but with a fitness defect compared to Btr WT. To 
investigate further the role of YopJ effectors during Btr infection, we performed a one-step in frame 
deletion of yopJ locus in Btr ΔbepA-I. The strain was then intradermally infected with Btr ΔbepA-I (Fig. 
9). We observed that the strain lost its infectivity, confirming a significant role of YopJs effector during 
Btr infection. 
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Figure 9. Deletion of YopJ triggers bacteremia impairments  
Bacteria were grown for 3 days at 35°C and 5% CO2 on Heart Infusion Agar (HIA) plates supplemented with defibrinated 
sheep blood. Plotted graphs represent time course of single animals from which bacteria were recovered at a given time 
point post-infection. Each value corresponds to an average (CFU/ml of blood) acquired from serial dilutions. Groups of 
10 weeks old Wistar rats were intradermally infected (inoculum 1x107 CFUs, n = 3) with either Btr ΔyopJ or Btr ΔyopJ 
ΔbepA-I or Btr WT.   
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Figure 14: Triad in Yersinia pestis 
In Yersinia pestis, the 288-bp length YopJ harbor a catalytic triad consisting of three amino acids: 
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Materials and Methods 
 
Bacterial strains and growth conditions  
The bacterial strains used in this study are listed in Table 1. Bartonella tribocorum strains were grown on HIA plates at at 35°C 
in a moist atmosphere under 5% CO2 for 2-3 days. When indicated, media were supplemented with 100 μg/ml streptomycin. 
E. coli strains were cultivated in LuriaBertani liquid medium (LB) or on Luria-Bertani agar on plates (LA) at 37°C overnight. 
When indicated, media were supplemented with 50 μg/ml kanamycin, 200 μg/ml ampicillin, 20 μg/ml gentamicin, 500 μM 
IPTG, and/or 1 mM diaminopimelic acid (DAP). 
 
Animal experimentation 
Animal handling was performed in accordance with the Swiss Animal Protection law and local animal welfare bodies. The 
animal experiments in this work were approved by the Veterinary Ofﬁce of the Canton Basel-Stadt (License number 1741). 
All animals were kept at SPF (speciﬁc pathogen-free) conditions. Animals were obtained from Janvier labs at the age of 8-10 
weeks. After two weeks of adaptation, rats were infected with bacteria harvested and diluted in phosphate-buffered saline 
(PBS) at OD595nm = 1. On anesthetized rats (1 – 3% isoflurane/O2 mixture), we performed either intradermal injection in the 
dermis of the ear (10 μl of the bacterial solution; 107 CFUs) or intradermal injection in the tail vein (200 μl of the bacterial 
solution; 2x108 CFUs). 
Blood samples were drawn and diluted (9:1) in PBS supplemented with 3.8 % of sodium-citrate, to prevent coagulation, and 
kept at -80°C for at least 1 hour. After thawing, blood samples were serial diluted in PBS and plated on appropriate agar plates 
(HIA plates). Then for counting, bacteria were incubated at 35°C and 5% CO2 for either 5-6 days for Btr. 
 
Medium composition 
Media Composition Quantity (g) for 1L 
Heart Infusion Agar (HIA) 
BDTM 
 
Beef Heart infusion from 500g 10.0 
Tryptose 10.0 
Sodium Chloride 5.0 
Agar 15.0 
   
Luria-Bertani Broth (LB) 
BDTM 
Tryptone 10.0 
Yeast extract 5.0 
NaCl 10.0 
   
Luria-Bertani Broth (LB) 
BDTM 
Tryptone 10.0 
Yeast extract 5.0 
NaCl 10.0 
Agar 15.0 
 
The powder mixed with 600 ml of ddH2O was autoclaved and supplemented with 4.2% (v/v) sterile defibrinated sheep’s 
blood  
TSA and HIA plates were supplemented with 5% of defibrinated sheep blood (Thermos FisherTM) 
 
Generation of spontaneous streptomycin-resistant strains 
Generation of the spontaneous streptomycin-resistant Btr strain RSE149 (CB0165) has been described previously by R. 
schulein [25]. In this study, the strain has been stocked as CB0165 after one additional in vitro passage of RSE149 on HIA agar 
plate. 
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Plasmid construction 
All primers used for the elaboration of this report are listed in table. 
The suicide mutagenesis vector pTR1000 used in this study was described previously [36]. 
pCB0007 used for generating Btr ΔA-I ΔvirD4 in-frame mutant was generated as follows. The homology region 1 (HR1), 
corresponding to the 1011 bp downstream virD4, was amplified from Btr ΔA-I (CB0265) with the oligonucleotide primers 
prCB120 and prCB114. The HR2, corresponding to the 978 bp upstream virD4, was amplified from Btr ΔA-I (CB0265) with the 
oligonucleotide primers prCB111 and prCB122. The amplified products were merged by SOEing PCR with the oligonucleotide 
primers prCB120 and prCB122. The 1989 bp-product was digested with XbaI and cloned into the suicide vector pTR1000, 
digested with XbaI and BamH1, to yield pCB007. Insertion of the SOEing fused-product within pTR1000 was confirmed by PCR 
with the oligonucleotide primers prCB116 and prCB117 spanning the insertion site. 
pCB009 used for generating Btr ΔA-I ΔvirD4 ΔvirB in-frame mutant was generated as follows. The HR1, corresponding to the 
1054 bp downstream virB2, was amplified from Btr SmR (CB0165) with the oligonucleotide primers prCB121 and prCB110. 
The HR2, corresponding to the 994 bp upstream bepI, was amplified from Btr SmR (CB0165) with the oligonucleotide primers 
prCB118 and prCB119. By SOEing PCR the amplified products were merged with the oligonucleotide primers prCB121 and 
prCB119. The 2048 bp-product was digested with BamH1 and XbaI and clones into the suicide vector pTR1000, digested with 
BamH1 and XbaI, to yield pCB009. Insertion of the SOEing fused-product within pTR1000 was confirmed by PCR with the 
oligonucleotide primers prCB116 and prCB117 spanning the insertion site. 
pKCB007 used for generating Btr ΔyopJ in-frame mutants was generated as follows. The HR1, corresponding to the 1024 bp 
downstream yopJ locus, was amplified from Btr SmR (CB0165) with the oligonucleotide primers prJK493 and prJK494. The 
HR2, corresponding to the 1041 bp upstream yopJ locus, was amplified from Btr SmR (CB0165) with the oligonucleotide 
primers prJK495 and prJK496. The amplified products were merged by SOEing PCR with the oligonucleotide primers prJK493 
and prJK496. The 2089 bp-product was digested with BamH1 and XbaI and clones into the suicide vector pTR1000, digested 
with XbaI and BamH1, to yield pKC007. Insertion of the SOEing fused-product within pTR1000 was confirmed by PCR with the 
oligonucleotide primers prCB116 and prCB117 spanning the insertion site. 
Procedure for gene replacement and confirmation of the mutants 
Following the mobilization of the suicide mutagenesis vector into the appropriate Bartonella strain, kanamycin was used as 
a positively selection step to isolate cointegrates. Growing bacteria that integrated the suicide mutagenesis vector by 
homologous recombination were selected by colony PCR spanning the two homology regions with the appropriate 
oligonucleotide primers. Then, cointegrates were negatively selected on a media supplemented with streptomycin. The 
surviving bacteria have lost the mutagenesis vector by a second homologous recombination leading to two situations; either 
the clone harbor the in-frame deletion or the restoration of the wild type conformation. Colony PCR spanning the region of 
interest was performed to isolate clones carrying the deletion by comparing the size of the generated PCR products.  
For Btr ΔA-I ΔvirD4 in-frame mutant, the oligonucleotide primers prCB120 and prCB122 (size expected 1989 bp) were used 
to select cointegrates after the positive selection and the oligonucleotide primers prMS056 and prPE336 were used to confirm 
the deletion (size expected 2484 bp). The oligonucleotide primers prMS056, prPE336, and prRS087 were used for sequencing 
(Microsynth AG).  
For Btr ΔA-I ΔvirD4 ΔvirB in-frame mutant, the oligonucleotide primers prCB121 and prCB119 (size expected 2048 bp) were 
used to select cointegrates after the positive selection and the oligonucleotide primers prRS045 and prPE336 were used to 
confirm the deletion (size expected 2444 bp). The oligonucleotide primers prRS045, prPE336 and prRS042 were used for 
sequencing (Microsynth AG). 
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For Btr ΔyopJ in-frame mutant, the oligonucleotide primers prCB137 and prCB138 (size expected 2137 bp) were used to select 
cointegrates after the positive selection and the oligonucleotide primers prRS135 and prPE136 (size expected 422 bp) were 
used to confirm the deletion. The oligonucleotide primers prCB137, prCB138 and prCB135 were used for sequencing 
(Microsynth AG). 
Synteny analysis 
The nucleic acid sequences of the three yopJ genes of Bartonella tribocorum IBS 506T (annotaded as yopJ1, yopJ2 and yopJ3) 
were compared to all Bartonella species of the NCBI database using the Basic Local Alignment Search Tool (BLAST) 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi). Interesting hits obtained with BLAST were reported in the following tables for the 
three yopJ genes with the corresponding accession numbers. Then, the accession numbers were reported in the UNIPROT 
database (www.uniprot.org) and to Geneious v.9.1.5. to establish the synteny of the yopJ genes in all Bartonella species.  
 
Accession numbers 
Strains 
 
YopJ1 YopJ2 YopJ3 
Lineage 4    
B. tribocorum (str. CIP 105476) WP_038474176.1 WP_012232336.1 WP_012232337.1 
B. tel Aviv WP_120099831.1 WP_120099832.1  
B. rattaustralian WP_019224003.1 WP_019224005.1  
B. queenslandensis WP_083868408.1 WP_039758348.1  
B. grahamii (str. as4aup) WP_015856898.1 WP_015856899.1  
B. rattismassiliensis (str. 15908) WP_007346374.1 WP_007346375.1  
B. washoeensis (str. 085-0475) WP_006926072.1 WP_006926071.1  
B. elizabethae (str. NCTC12898) WP_005775257.1   
B. taylorii (str. 8TBB) WP_004857668.1   
B. vinsonii (str. Winnie) WP_004866265.1   
B. alsatica (IBS 382) WP_005866866.1   
B. OE 1-1 WP_120121107.1   
B. quintana (str. Toulouse) WP_011179798.1   
    
Lineage 3    
B. clarridgeiae (str. 73) WP_013545275.1 WP_013545271.1 WP_013544601.1 
B. 1-1C WP_100693030.1 WP_100693917.1 WP_100693917.1 
B. rochalimae (ATCC BAA-1498) WP_035006140.1 WP_035006135.1 WP_035006322.1 
B. JB15 WP_078719099.1 WP_078719097.1 WP_078718558.1 
B. BAR15-3  WP_078679996.1 WP_078679862.1 
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YopJ proteins phylogenetic analysis 
The phylogeny of YopJ proteins among Barotnella spp. was built from 23 Bartonella spp. and 3 outgroup species (Y. pestis, Y. 
enterocolitica, Y. pseudotuberculosis) based on the alignment of the amino sequences of the three different YopJ proteins 
present in Bartonellaceae and in the outgroup species with Geneious v9.1.5. (https://www.geneious.com).  
Statistical analysis 
Statistical analysis of the obtained data was performed using GraphPad Prism SoftwaRE. Depending on the experiment I used 
either the T-test or the two-way ANOVA to compare bacteremia curves. This information is indicated in the figure legends. P-
valuet-test indicates the p-value calculated by the t-test and P-valueANOVA indicates the p-value calculated by the two-way 
ANOVA. 
 
Strain 
 
Genotype or relevant characteristics 
 
Reference 
 
 
  
Bartonella tribocorum 
 
 
RSE149 Spontaneous SmR strain, used as WT in this study [8] 
RSE256 ΔvirD4, derivative of RSE149 [8] 
RSE266 ΔvirD4 pvirD4, derivative of RSE149 [8] 
RSE173 ΔvirB4, derivative of RSE149 [8] 
CB0265 ΔbepA-I, derivative of RSE149 This study 
C83B0320 ΔbepA-I ΔvirD4 mutant, derivative of CB0265 This study 
CB0322 ΔbepA-I ΔvirD4 ΔvirB mutant, derivative of RSE149 This study 
CB0204 ΔbepA-I, derivative of RSE149 This study 
CB0411 ΔyopJ, derivative of RSE149 This study 
CB0426 ΔbepA-I ΔyopJ, derivative of CB0411 This study 
   
   
Escherichia coli   
   
JKE217 MFDpri ΔT IV lacIq, DAP auxotroph (1mM) 
Conjugative strain used for Bartonella 
[33] 
CB128 Strain used for transformation This study 
   
Plasmid Genotype or relevant characteristics Reference 
 
pTR1000 Basic suicide mutagenesis vector for Bartonella [34] 
pTRΔvirD4 Suicide mutagenesis vector for virD4 deletion in CB0126 [33] 
pCB007 Suicide mutagenesis vector for virD4 deletion in CB0265 This study 
pCB009 Suicide mutagenesis vector for virD4, virB locus and bepA-I deletion in 
CB0165 
This study 
pKCB007 Suicide mutagenesis vector for yopJ deletion in CB0165 and CB0265  This study 
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Primers 
 
Sequence Reference 
prCB0013 ATGCTTAATTAAGGTTCTGGCAAATATTCTGA This study 
prCB0014 ATGTCCTAGGGCCTGCAGTTATTTGTATAG This study 
prCB0111 AAGTCTCTATACCCCCCATACACCAACCAATAGCGACACCAATC This study 
prCB0116 GGAGCGGATTTGAACGTT This study 
prCB0117 GTGCTCAACGGGAATCCT 
 
This study 
prCB0118 AAGTCTCTATACCCCCCATACACCAAGTCCTTGCCAAAAGAACAG This study 
prCB119 ACTGTCTAGATTTCTCTCTAGGGGGATGTT This study 
prCB0120 CGTATCTAGACTTCATTCCACAACGCTCAA This study 
prCB121 CGTATCTAGAGCATGATGATACTGTGTTGGA This study 
prCB122 ACTGTCTAGATTGTTTGCAAGAGCACCTT This study 
prCB126 TTGTTTGCAAGAGCACCTT 
 
This study 
prCB135 GCCCTCTAGACTTCTGACAATT This study 
prCB136 GCTTTGAGCCAATAAGAGCTTT This study 
prCB137 CAACACCCAGCCTCCAAT This study 
prCB138 GGTATGACCATAGCCGATTGT This study 
prMS056 GGGTTGAAGGAAAATTTAAGG This study 
prRS045 TTATTAATCTGCTTTCTATCTCA [25] 
prPE336 CAACAAGAGTGCGTGAAGAC This study 
prRS042 TCGCTCAAAAAATTCATTGTT This study 
prRS087 CAAATTTATTGGACTCTTCGTTC This study 
prJK493 GAGCCGGGATCCAACCTTAACACTTGCGATCC This study 
prJK494 TTTCATCATATCAACCTTTTTCTTG This study 
prJK495 GAATAGAGAAAAAAATGTCAATTACATCATTTTTCATCATATCAACCTTTTTCTTG This study 
prJK496 GAGCCGGTCGACATTTTCCTCATTTGCTTCTCC This study 
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Discussion 
 
Among Gram-negative and Gram-positive bacteria, type 4 secretion systems are extensively spread. 
The number of newly-discovered bacteria using these systems during infection process continues to 
expand and includes some clinically-important human pathogens such as Helicobacter pylori, 
Legionella pneumophila, Bordetella pertussis, Brucella and Bartonella species [3-5]. In Bartonella 
species, the VirB/D4 T4SS contributes to pathogenicity by translocating Beps. Previous study where 
rats were intravenously infected with either Btr ΔvirD4 or Btr ΔvirB4 shows that these strains are 
abacteremic indicating the dependency of Bartonella on the VirB/D4 T4SS and on the effector 
translocation process to establish infection [25].  
So far, in vitro studies on ECs have linked several known Bartonella phenotypes with Bep translocation 
[34-36]. BepD modulates host immune response by increasing anti-inflammatory cytokine (IL-10) and 
by reducing the production of pro-inflammatory cytokines (TNFα) (Unpublished data). BepC, BepF, and 
BepG trigger cytoskeletal rearrangement resulting in cell invasion in a unique cellular structure called 
invasome [19, 37]. BepA protects infected cells from apoptosis by increasing cAMP concentration and 
BepE is required for Bartonella dissemination through the dermis [7, 35]. Based on these observations 
we first thought that Bep were crucial for Bartonella to establish bacteremia but the bacteremic 
phenotype of Btr ΔbepA-I drove us to reconsider the essentiality of Bep during the infection process.  
Beps are not crucial for Bartonella dissemination from the inoculation site to the lymphatic circulation 
and subsequently to the bloodstream. Nevertheless, the delayed bacteremia onset observed in both 
conditions (i.d. and i.v.) could be associated with the loss of effectors. Indeed, evasion of the innate 
immunity is a prerequisite for Bartonella to travel from the inoculation site to the bloodstream [38]. 
By lacking Beps, Btr ΔbepA-I might be less effective compared to the WT to escape from the immune 
system and to travel through the dermis making the colonization of the host more challenging. The 
lost capacity to modulate the immune response might also facilitate the clearance of the pathogen by 
immune cells, explaining the shorter bacteremia. 
After the first bacterial release in the bloodstream, bacteremia reaches the same titer for both strains. 
Presumably, the first wave of infection corresponds to the release from the lymphatic nodes [39], 
suggesting that Beps are not crucial for bacterial replication and release in the bloodstream. 
Furthermore, in our model, bacteria intravenously injected are rapidly cleared from the bloodstream, 
which remains sterile for at least three days post inoculation. From this observation we believe that 
bacteria might invade the lymphatic circulation, which represents a crucial step during Bartonella 
infection, before RBC invasion. Indeed, the Trw T4SS, which is essential for erythrocyte colonization, is 
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under the control of the two-component system BatR/BatS, which displays an optimum activity at the 
physiological pH 7.4 [40-42]. Therefore, by infecting the lymphatic circulation, we  assume that 
Bartonella replicates and is reprogrammed for the invasion of RBCs. Up to date, the exact process 
leading to the release is still unknown but might be tightly regulated [39, 43]. Indeed, independently 
of the initial concentration used for infection (inoculum 107, 105 or 102 CFUs), the bacterial load reaches 
a concentration around 106 CFUs/ml when released in the bloodstream. 
As described in the introduction, after the first release Bartonella invades erythrocytes and endothelial 
cells, designated as the “blood-seeding” niche. The “blood-seeding” niche is believed to seed 
additional waves of bacteria in the bloodstream by regular interval (5 days) until the immune response 
blocks the infection [8, 43]. Another hypothesis to explain the shorter bacteremia is the inability of Btr 
ΔbepA-I to invade the replicative “blood-seeding” niche. Thus, following the release from the lymphatic 
circulation Bartonella colonizes only erythrocytes - which is a VirB/D4 TSS independent process [40]- 
and is progressively cleared with the natural erythrocytes recycling process by the spleen. However, 
our read-out does not allow us to state the loss of these cyclic-infection waves for Btr ΔbepA-I. Thus, 
it would be interesting to test this hypothesis by a biotinylation assay on blood infected with Btr ΔbepA-
I gfp, as described by R. Schulein [8].  
Taken together our results demonstrate that Beps are not essential for Bartonella to establish 
bacteremia in the infected host but facilitate the colonization and contribute to maintain a sustainable 
intraerythrocytic infection. To explain the abacteremic phenotype of Btr ΔvirB4 and Btr ΔvirD4, two 
hypotheses have been submitted (i) Is there a toxic accumulation of Beps within bacteria due to the 
inability to translocate effectors? (ii) Does the VirB/D4 T4SS translocate another protein(s) different 
from Bep? 
We showed that bacteria expressing a VirB/D4 T4SS without the coupling proteins and the effectors 
(Btr ΔvirD4 ΔbepA-I) were abacteremic thereby refuting a potential toxicity associated with an 
accumulation of Beps. Furthermore, the fact that Btr ΔbepA-I is bacteremic and Btr ΔbepA-I ΔvirD4 is 
abacteremic confirmed the significance of the coupling protein VirD4 for Bartonella to establish a 
successful infection. 
Since the coupling protein VirD4 and the VirB/D4 T4SS were shown to be crucial for Bartonella to 
establish bacteremia we assumed that the VirB/D4 T4SS might translocate another protein during 
infection. Interestingly, a study from 2004 revealed in B. quintana the presence of a gene with high 
similarity to yopP (Yersinia outer protein P) expressed in Yersinia enterocolitica (termed yopJ in Y. pestis 
and Y. pseudotuberculosis) [29, 44]. Yersinia YopJ/P proteins were the first described representatives 
of an effector family widely distributed among different bacterial genus such as animal pathogen 
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(Salmonella spp., Vibrio spp., Aeromonas spp.), plants pathogens (Pseudonomas syringae, 
Xanthomonas spp., Ralstonia spp.) or plant symbionts (Rhizobium spp.) [28, 32, 45]. YopJ and YopJ-
related proteins are acetyltransferases and most of these effectors share a catalytic triad consisting of 
Histidine/Glycine/Cysteine (Fig. 14) [28]. Even though some exceptions have been reported, such as 
PopP2 from Ralstonia solanacearum that exhibits an Asparagine rather a Glycine, all YopJ-related 
effectors harbor a conserved cysteine [28, 32, 46]. To this conserved cysteine is attributed the 
acetyltranferase activity of the protein which modifies preferentially serine and threonine of the target 
by using acetyl-coenzyme A (CoA) as substrate [46].  Although, it has been reported that the YopJ-like 
effectors PopP2 (Ralstonia spp.) and VopA (Vibrio spp.) are also able to modify a lysine residue. In our 
phylogenetic tree of YopJ, we are the first one to show that YopJ is widely distributed among lineage 
3 and lineage 4 Bartonella species. Furthermore, the protein alignment confirms that all YopJ proteins 
present in Bartonella spp. harbor this characteristic catalytic triad (H/G/C) with the conserved cysteine. 
Considering that almost all Bartonella spp. from lineage 3 and 4 exhibit up to three copies of yopJ in 
their genome and the catalytic triad is well-conserved, we assum that the protein is still functional and 
might play a role during infection. This assumption is supported by the fitness decrease observed for 
Btr ΔbepA-I ΔyopJ and Btr ΔyopJ.  
Our yopJ synteny analysis in Bartonella species suggest that yopJ was independently acquired in 
lineage 3 and lineage 4 species. Indeed, in all lineage 4 species, we observe a conserved synteny where 
yopJ is always nearby a gene coding for a lysozyme. In all lineage 3 species we found three yopJs in two 
different loci where yopJ1 and yopJ2 are localized in the same locus whereas yopJ3 is isolated in a 
second one. However, similarly to lineage 4 species, we observe in lineage 3 species a common yopJ 
synteny shared by all lineage 3 species for the two loci.  
In lineage 4 species, the number of yopJ genes varies between one to three copies. Therefore, we 
suppose that a single copy of yopJ was acquired by the common ancestor of lineage 4 species and the 
duplication and differentiation events occurred after speciation. This assumption is supported by the 
independent duplication event of yopJ1 in B. washoeensis and in the common ancestor of three species 
B. tribocorum, B. grahamii and B. rattimassiliensis [31].  In B. tribococurm, we believe also that a 
specific duplication event of yopJ2 occurred recently leading to the appearance of yopJ3. Unlike lineage 
4, all lineage 3 species bear three yopJ orthologs with a similar synteny suggesting that the duplication 
and differentiation events occurred before speciation. 
Pathogenic Yersinia spp. (Y. pestis, Y. enterocolitica and Y. pseudotuberculosis) differ from non-
pathogenic ones by the presence of a 70-kb virulence plasmid names pCD in Y. pestis or pYV in Y. 
enterolitica and Y. pseudotuberculosis [47, 48]. It encodes the Yop virulon consisting of structural 
components of the Ycs apparatus, a T3SS, regulatory proteins and effectors including YopJ (to notice, 
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YopJ is named YopP in Y. enteroliticolitica) [49]. Up to date, yopJ is the only gene identified in Bartonella 
species from the well-characterized yop genes [50]. So far, it is difficult to determine how and when 
Bartonella acquired yopJ but we assume it was from a species either encoding the Yop virulon or 
harbouring a yopJ-like gene. Bacteria are known to exchange DNA via horizontal gene transfer (HGT) 
mechanisms allowing transmission of virulence factor or antibiotic resistances [51].  Since it has been 
demonstrated that Yersinia and many other pathogens are transmitted by fleas like several Bartonella 
spp. [52-54], we cannot exclude that Bartonella acquired a copy of yopJ in the midgut of an arthropod 
via a HGT mechanism such as conjugation, transduction, transformation or the gene transfer agent 
(GTA) [55-57]. Finally, to clarify how Bartonella acquired YopJ we need to deepen our phylogenetic 
analysis (i) by appending more YopJ amino acid sequences from other Bartonella species that will be 
newly sequenced and, (ii) by comparing to Bartonella the yopJ synteny from other α-proteobacteria 
with Bartonella. 
In Yersinia, YopJ/P dampens the host immune system by targeting and subsequently inhibiting the 
activity of the MAPK family and the nuclear factor кB (NF-кB) [28, 58, 59].  Furthermore, it has been 
demonstrated that the YopJ-related protein AvrA (Salmonella Typhimurium) also acts on the MAPK-
JNK signaling pathway by interacting with MKK7 and MKK4 and modulates NF-кB production by 
interacting with TNFα [60-62]. Or still, AopP (YopJ-like protein in Aeromonas) also regulates the 
immune response by disrupting the NF-кB signaling cascade [63].Taking into account the role of these 
YopJ-like proteins in different species, we presume that YopJ in Btr might also interfere with the 
immune system of the host, justifying the infectious phenotype of Btr ΔbepA-I. Furthermore, to 
prevent apoptosis of infected-macrophage by modulating the JNK pathway, AvrA allows rapid 
dissemination of the bacteria to the spleen [64].  In Y. pestis, YopJ promotes dissemination from the 
inoculation site to the lymph nodes, which takes less than one hour [65, 66]. We can suppose that, in 
a similar way to YopJYpes and AvrA, YopJBartonella prevents apoptosis of immune cells during Bartonella 
infection and subsequently allows the dissemination of the bacteria from the inoculation site to the 
lymphatic nodes.  
In Yersinia, Yop proteins are Type 3 effectors (T3Es) and translocation signal is related to their 15 
residues of the NH2 terminus [67, 68]. Considering YopJ as a T3E and Bartonella spp. expressing a T4SS 
rather than a T3SS [12, 28], different observations lead us to suggest that YopJ evolved as a VirB/D4 
T4SS effector. First, yopJ is present only in Bartonella spp. expressing a virB/D4 T4SS. Secondly, when 
we disrupt the three copies of yopJ in Btr ΔbepA-I background, Btr ΔbepA-I ΔyopJ loses its infectivity. 
Finally, when we either disrupt the assembly of the VirB/D4 T4SS (Btr ΔvirB4) or we prevent the 
expression of the coupling protein VirD4 (Btr ΔvirD4), mutants turn into non-bacteremic confirming 
the essentiality of VirD4 and the VirB T4SS for YopJ recognition and/or translocation. 
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Results of preliminary cytokines-measurement experiments performed in Prof. Christoph Dehio’s 
group (unpublished data) support the assumption that YopJ is involved during Bartonella infection by 
modulating the immune system as observed in other species expressing YopJ-like proteins (AvrA 
Salmonella, YopJ Yersinia, VopA Vibrio…). Indeed, known to be a YopJ lacking species, B. henselae 
modulates the immune response through the action of BepD that on one hand increases anti-
inflammatory cytokines production (IL-10) and on the other hand decreases pro-inflammatory 
cytokines (e.g. TNFα) (data not shown, personal communication) [29]. Interestingly, BepD in B. taylorii, 
which also expresses YopJ, modulates IL-10 production but did not have any effect on TNFα 
production. Known to decrease the production of NF-kB in Yersinia spp., we could assume that YopJ in 
B. taylorii modulates NF-кB by interacting with TNFα. Furthermore, since YopJ is not express in B. 
henselae and that BepD operates at two-level (IL-10 and TNFα production), we suggest that during 
evolution BepD substitutes the role of YopJ in B. henselae.  
Finally, it has been shown in Y. pestis that YopJ contributes to pathogenicity although without being 
crucial for its virulence [69]. Similarly to Y. pestis, when we infect rat with Btr ΔyopJ we still observe 
bacteremia but with a shorter duration indicating that YopJ plays a role but is not essential for 
bacteremia establishment. Furthermore, the fact that Btr ΔyopJ and Btr ΔbepA-I trigger impaired 
bacteremia in the infected rats whereas Btr ΔyopJ ΔbepA-I lose totally its ability to establish bacteremia 
point out that YopJ effectors and Beps might be translocated simultaneously and act in synergy to 
establish an efficient long-lasting infection.  
In summary, this study allows to advance our understanding of the infection process of Bartonella 
species. By using i.d. and i.v. infection models we show that Bartonella effectors (Beps) are not 
essential for bacteremia establishment but play a role for maintaining a sustainable infection in the 
host. Our in silico analysis revealed for the first time that two sister clades (lineage 3 and lineage 4) of 
the Bartonella genus might have acquire independently a single yopJ gene encoding for a YopJ-like 
protein. Depending on the species and lineage we assume that acquisition of yopJ was followed by 
rounds of duplication and differentiation events. Previously described as T3SE, our preliminary results 
strongly indicate that YopJ evolved as a T4SE in Bartonella species and might cooperate with Beps to 
enable Bartonella to successfully infect its host. These preliminary results give a new perspective 
concerning Bartonella infection process but need further studies. First of all, infection with Btr ΔyopJ 
complemented strain would be crucial to confirm the involvement of YopJ during infection. 
Furthermore, it would be relevant to characterize the target of the effector and confirm that the 
conserved-triad is also carrying the enzymatic activity of the protein in Bartonella species. Last but not 
least, it would be important to confirm that YopJ is translocated via the VirB/D4 T4SS in Bartonella 
species which will provide a new perspective concerning evolution of effectors in bacteria. 
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Additional Results 
 
Up to date, Bep targets in vivo are not well characterized yet and need further investigation. Since Fic 
domain-containing Beps are known to catalyze posttranslational modifications such as AMPylation, 
phosphorylation or phosphocholination we focused our in vivo researches on the Fic-containing 
effecors in Btr: BepA, BepC and BepI [1-3]. Therefore, different mutants were generated: Btr ΔbepA, 
Btr ΔbepC, Btr ΔbepI, Btr ΔbepAC, Btr ΔbepCI, Btr ΔbepACI and Btr ΔbepDHEF.  
 
 
BepA and BepC seem to have a redundant function  
 
Rats infected with either Btr ΔbepA or Btr ΔbepC developed bacteremia that was not significantly 
different from rats infected with Btr WT (p-value = 0.1845 and 0.8165, respectively) suggesting that 
there was no impact on the bacterial fitness associated with the loss of either bepA or bepC. 
Interestingly, when we intradermally infected rats with Btr ΔbepAC, we observed strong bacteremia 
impairments with a delayed onset (16 d.p.i.), a shorter duration (36 days) and a lower maximum titer 
(9.9x104 CFUs/ml of blood on average). Statistical analysis indicated that bacteremia curve triggered 
by Btr ΔbepAC was significantly different from Btr WT. (p-value = 0.0094). Based on these observations, 
we hypothesized a redundant role between BepA and BepC explaining the similar kinetics of Btr ΔbepA 
and Btr ΔbepC with Btr WT and the strong bacteremia impairments observed for Btr ΔbepAC. 
Furthermore, BepA and BepC might be involved in bacteremia establishment and duration explaining 
the delayed onset and the shorter duration.  
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Btr ΔbepA 
Figure S1. Beps: Redundant activities and collaboration for the establishment of a long-lasting bacteremia 
Bacteria were grown for 3 days at 35°C and 5% CO2 on Heart Infusion Agar (HIA) plates supplemented with defibrinated 
sheep blood. Plotted graphs represent an average CFU/ml of blood in animals groups (n = 3) from which bacteria were 
recovered at a given time point post-infection. (A) Groups of 10 weeks old Wistar rats were intradermally infected (inoculum 
107 CFUs, n = 3) with Btr WT, Btr ΔbepA, with Btr ΔbepC or Btr ΔbepAC. (B) Groups of 10 weeks old Wistar rats were 
intradermally infected (inoculum 107 CFUs, n = 3) with Btr WT, Btr ΔbepA, with Btr ΔbepC or Btr ΔbepAC. Groups of 10 weeks 
old Wistar rats were intradermally infected (inoculum 107 CFUs, n = 3) with Btr WT, Btr ΔbepI, with Btr ΔbepAC or Btr 
ΔbepACI. (C) Groups of 10 weeks old Wistar rats were intradermally infected (inoculum 107 CFUs, n = 3) with Btr WT, Btr 
ΔbepACI or Btr ΔbepDHEF. Statistical analysis was performed using two-way ANOVA and results are annotated as p-values. 
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Beps ACI collaborate to enable a long-lasting bacteremia  
 
To assess the role of BepI during Btr infection, we infected intradermally with Btr ΔbepI. Compared to 
the bacteremia curve triggered by Btr WT, there was a significant decrease of the bacterial fitness 
associated with the deletion of bepI (p-value = 0.0127). Since bacteremia onset is similar with WT, BepI 
is not involved in bacteremia establishment but rather had a role in maintaining a long-lasting 
bacteremia in the host (43 ± 4.7 d.). Surprisingly, rats infected intradermally with Btr ΔbepACI and Btr 
ΔbepCI developed a bacteremia that was not significantly different from bacteremia induced by Btr 
WT (p-value = 0.2522 and 0.4606, respectively). Taken together, we assumed that BepA/BepC and BepI 
have compensatory effects and might act in synergy to induce a successful and long-lasting bacteremia. 
This might explain why when we disturbed this balanced collaboration by removing either bepC/bepA 
or bepI we affected the fitness of the bacteria and, when we deleted simultaneously these three genes 
we observed a bacteremia kinetic similar to WT. To confirm this assumption, it would be relevant to 
infect rat with Btr ΔbepAI. 
 
Beps DHEF are essential to establish a long-lasting bacteremia  
 
Finally, we generated a strain expressing only beps harboring a Fic domain: Btr ΔbepDEHF. Rats 
intradermally infected with Btr ΔbepDEHF developed bacteremia with significant impairments in the 
duration compared to Btr WT (p-value = 0.0005). However, no impact of the deletion on the 
bacteremia onset was observed. These observations indicate that Beps DEHF have a key role in 
maintaining a sustainable bacteremia.  
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Discussion 
 
Our results highlight a putative functional redundancy between BepA and BepC. This assumption is in 
accordance with a general biological principle, where functional redundancy contributes to an increase 
of  the robustness of relevant mechanisms such as infection process [4]. Furthermore, redundant 
activities has been previously demonstrated in vitro for B. henselae where either BepC/F or BepG 
trigger engulfment and internalization of bacteria cluster within a host cellular structure surrounded 
by actin named invasome [5-7]. Up to date, we know in vitro that BepA prevents DC apoptosis and 
BepC is involved in cell migration which do not support our assumption of redundancy [8-10]. However, 
we cannot exclude that there are still other uncharacterized targets for these effectors that could 
explain this hypothetic redundancy between BepA and BepC. Nevertheless, in accordance to the 
activities described so far for BepA and BepC, we can assume that without these effectors it is more 
challenging for the bacteria to travel from the inoculation site to the bloodstream explaining the 
delayed onset. Our results also indicate that BepI and BepsDHEF might be involved in maintaining a 
sustainable bacteremia. However, the target of these effectors remains so far undetermined and 
prevent any conclusion about their contribution during the infection process.  Finally, our results show 
that BepA/C and BepI might have compensatory effects and need to act in synergy to trigger a 
successful infection.  
Based on these preliminary results, we can assume that several Beps might display redundant activities 
others might act in synergy to increase the chance of Bartonella to trigger a sustainable infection. 
However, the lack of knowledge concerning the targets of Beps prevents any conclusion about their 
contribution during the in vivo infection process and needs further studies to enhance our 
understanding.  Although we have to be cautious with these preliminary results, they provide a good 
basis for further in vivo and in vitro investigations. 
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General Conclusion and Outlook 
The first part of my thesis aimed to establish a lineage 3 in vivo infection model by using B1-1C to 
afterward investigate the role of the flagellum and the VirB/D4 T4SS and its lineage 3-specific Beps.  
To study at which stage of Bartonella 1-1C infection the virulence factors play a role I have established 
the rat intradermal (i.d.) and intravenous (i.v.) infection model. The i.d. injections reflect the natural 
route of transmission by arthropods, while i.v. injections bypass the dermal stage. Whereas i.v. 
injections are reliable independently of the growth medium, i.d. injections require specific growth 
conditions to trigger reliable infections. Growing bacteria either on TSA for 3 days or on HIA for 10 days 
at 35 °C with 5% CO2 in a moist atmosphere is necessary. It is believed that prior invading the host 
Bartonella spp. have to express the VirB/D4 T4SS. Since the expression of this virulence factor is under 
the control of the stringent response RpoH1 and the BatR/BatS two-component system, TSA medium, 
as a long-time growth on HIA medium, provide an environment triggering expression of the VirB/D4 
T4SS. To confirm this hypothesis, it would be interesting to chromosomally express within Bartonella 
a gfp cassette under the control of the natural promoter of the virB operon. Therefore, by FACS analysis 
we could indirectly assess expression over time of the VirB/D4 T4SS on HIA and TSA media. 
Furthermore, it might be interesting to also test CBA medium. 
Since I established appropriate conditions for reliable i.d. and i.v. infections rats were infected via the 
two routes. The i.v. infected animals develop bacteremia around 6 days post-inoculation while it takes 
around 18 days for i.d. infected animals. The delay observed for i.d. injections might be associated with 
the time needed for the bacteria to travel from the inoculation site to the bloodstream and to subvert 
immune system of the host. Furthermore, i.v. infected animals develop bacteremia 6 days post-
inoculation revealing the necessity of Bartonella to invade a replicative blood seeding niche.  
Compared to the lineage 4 strain B. tribocorum, rats intradermally infected with B1-1C develop a 
bacteremia 17 days post-inoculation while it takes 8 days for rats intradermally infected with Btr. 
Because of the lack of knowledge during the early stage of infection and the lack of in vitro experiment, 
it is difficult to explain this delay observed for B1-1C. However, if rat is considered as an accidental host 
we can assume that B1-1C is not adapted to rat and might undergo disturbances to reach the 
bloodstream and/or subvert host immune system.  
Furthermore, bacteremia triggered by B1-1C persists in the host for around 11 days while bacteremia 
induced by Btr lasts around 64 days. Since Bartonella infection is characterized by long-lasting 
erythrocytic parasitism, this short duration is surprising. This finding suggests that B1-1C might use a 
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different strategy from the stealth strategy used by lineage 4 Bartonella species or might not be specific 
to rat.  
Since B1-1C is triggering a short bacteremia duration, we analyzed the behavior of the bacteria within 
the blood by FACS analysis and Gentamicin protection assay. With both analysis I demonstrated that 
B1-1C is unable to colonize rat erythrocytes. Up to date, all Bartonella species are able to invade 
erythrocytes and such inability is associated with the accidental infection of a non-specific host. 
Furthermore, the disability of B1-1C to colonize erythrocytes, which protect bacteria from immune 
cells, explains the short bacteremia duration. Indeed, by circulating in the blood as a single cell, 
bacteria is no more protected and is easily cleared from the bloodstream by the immune system. 
Nevertheless, B. bacilliformis is known to have a hemolytic activity [1]. Therefore, it would relevant to 
establish an in vitro model to exclude on one hand that B1-1C displays a hemolytic activity and on the 
other hand to confirm that the bacteria are not able to interact and/or invade rat erythrocyte.  
Infections with different B1-1C mutants, complemented strains and revertant strains highlight a fitness 
attenuation associated with genetic engineering preventing the study of the virulence factors such as 
the flagella, the virB/D4 T4SS and lineage 3-specific Beps. Bartonella species are considered as 
fastidious bacteria and any genetic manipulations require many in vitro passages supplemented with 
long incubation in the appropriate conditions. Therefore, we assume that the loss of infectivity 
observed for B1-1C is associated with genetic engineering and/or successive plating. Establishment of 
an in vitro model would be useful to determine if our genetic engineering has an impact on the 
bacterial growth and subsequently on the infection process clarifying the abacteremic phenotypes of 
the mutants. 
Bartonella 1-1C strain used in our experiments was isolated by Lin et al. in 2008 from 1 rat (R. 
norvegicus) out of 58 tested. The small sample size of animals tested and the very low prevalence of 
B1-1C question the relation between B1-1C and rat. Considering rat as an accidental host might explain 
why: 
- B1-1C is extremely demanding on the growth media for reliable i.d. infection, while such 
requirement has, up to date, never been mentioned for other Bartonella species. 
- Genetic engineering has a strong impact on its infectivity. 
- B1-1C needs around 17 days to travel from the inoculation site to the bloodstream, while other 
Bartonella species take around 1 week to induce bacteremia [2-4] 
- Bartonella 1-1C is not able to invade erythrocytes, which is one hallmark of Bartonella infection 
even for flagellated species [5]. 
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Although our results suggest that rat is an accidental host for B1-1C, it needs further investigations to 
confirm this hypothesis. Therefore, it seems crucial to characterize the bacteremia kinetic of other 
lineage 3 species such as the cat-specific B. clarridgeiae or the red squirrel-specific B. AR15-3 strains 
Then, if these experiments confirm the extraerythrocytic life style of B1-1C, our in vivo model will be a 
good experimental basis for further investigations and enhance our knowledge about the infection 
process of Bartonella species. 
The second part of my thesis intended to investigate the contribution of the VirB/D4 T4SS and its 
effector proteins during Bartonella tribocorum infection in vivo.  
The i.d. and i.v. infected rats with Btr ΔbepA-I develop an impaired bacteremia characterized by a 
delayed onset and a shorter duration indicating a fitness loss for the Bep-free mutant. This phenotype 
indicates that Bep are not crucial for bacteremia establishment but maintain a sustainable bacteremia 
in the host. The exact in vivo contribution of Beps during infection remains unclear and so far, our 
knowledges are based on in vitro experiments. However, Beps might display redundant roles, 
compensatory effects and synergic activities to trigger a long-lasting bacteremia. Therefore, the next 
step would to extend in vivo infections with other Beps mutants. Thus, by combining in vivo and in vitro 
analysis it will provide a more accurate knowledge about Beps functions during the Bartonella infection 
process. 
Furthermore, in this study we demonstrate the essentiality of the VirD4/T4SS and its coupling protein 
VirD4. Since we show that Beps are not essential for establishing bacteremia, we hypothesized the 
translocation of another effector. Our in silico analysis reveal for the first time that two sister clades of 
the Bartonella genus (lineage 3 and lineage 4) might have acquired independently a single yopJ gene 
encoding and, depending on the strain, was followed by duplication and differentiation events. Since 
our in silico analysis is based only on Bartonella species that have been so far sequenced, it seems 
relevant to append to this analysis the future sequenced species in order to have a more accurate 
overview of the distribution of YopJ proteins among the Bartonella genus. Furthermore, it would be 
relevant to compare Bartonella yopJ synteny with other α-proteobacteria to clarify how yopJ was 
acquired by Bartonella species. 
In this study we suggest the involvement of YopJ during Bartonella infection. However, to verify this 
hypothesis it seems crucial to complement Btr ΔyopJ and Btr ΔyopJ ΔbepA-I strains by expressing yopJ 
in trans as previously described [2, 6]. Therefore, if we restore the WT phenotype for Btr ΔyopJ pyopJ 
and the Btr ΔbepA-I phenotype for Btr ΔbepA-I ΔyopJ pyopJ it will exclude any pleiotropic effect of the 
deletion and confirm the contribution of YopJ during Bartonella infection.  
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The abacteremic phenotypes observed for Btr ΔvirD4 and Btr ΔvirB4 and the finding that YopJ is 
expressed only in species harboring the VirB/D4 T4SS suggest that YopJ might be translocated by The 
VirB/D4 T4SS. Since YopJ was previously characterized as a T3S effector in Y. perstis, it would be 
interesting to verify if YopJ evolved as a T4SE in Bartonella species by expressing in-trans in Btr ΔbepA-
I ΔyopJ a chimeric YopJ protein with a tag localized either in the N-terminus or in the C-terminus of the 
protein. Therefore, in vitro infection of nucleated cell combined with an immunofluorescence assay 
will allow us to determine if the YopJ is translocated via the VirB/D4 T4SS. Furthermore, if the tag is 
added to the protein extremity harboring the secretion signal it might prevent the translocation and 
therefore could inform about the secretion signal localization. To notice, in Y. pestis the secretion signal 
is localized in the last 15 residues of the NH2 terminus of Yop effectors [7].  
YopJ and YopJ-related proteins are acetyltransferase known to prevent phosphorylation of NFкB [8]. 
Therefore, it would be interesting to determine in vitro if YopJ from Bartonella species also prevent 
NFкB phosphorylation. Furthermore, the catalytic activity of YopJ and YopJ-like proteins is 
systematically allocated to the cysteine of the catalytic triad and it has been shown that the mutant 
YopJ (C172A) is catalytically inactive [8-12]. To confirm that the enzymatic activity is also carried by the 
cysteine in Bartonella-YopJ effector, it could be relevant to transfect eukaryotic cells with a plasmid 
encoding for YopJ protein with a point mutation on the cysteine and assess its enzymatic activity.  
 
To conclude, the discovery of YopJ among Bartonella species gives a new perspective on the infection 
process and further investigations will clarify its contribution. Furthermore, our preliminary results 
concerning the Beps combine with in vitro knowledge provide a good basis for the understanding of 
their role but need more investigations to in fine provide a more accurate overview of the general 
process of infection of the Bartonella genus. 
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HIA  heart infusion agar 
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i.v.  intravenous infection 
ml  milliliter 
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Yop  Yersinia outer protein 
WT  wild type 
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